arginine and Breast Cancer

arginine has been researched along with Breast Cancer in 173 studies

Research

Studies (173)

TimeframeStudies, this research(%)All Research%
pre-199014 (8.09)18.7374
1990's24 (13.87)18.2507
2000's54 (31.21)29.6817
2010's52 (30.06)24.3611
2020's29 (16.76)2.80

Authors

AuthorsStudies
Chen, M; Fu, D; Huang, X; Lv, Z; Su, D; Zhang, W; Zhang, Y1
Chen, W; Hou, R; Li, Q; Liang, H; Yang, Y; Zhang, Y1
Hou, Y; Liu, X; Su, R; Xu, J; Yang, T; Zhao, M1
Zaki Mahdi, N1
Feng, X; Gu, J; Han, W; Hu, X; Huang, J; Ji, Z; Lei, L; Li, F; Li, L; Li, N; Ren, W; Sun, C; Wang, T; Wu, Z1
Abdelraof, M; Allam, RM; Hassabo, AA1
Avtandilyan, N; Bartoszek, A; Ginovyan, M; Jakubek, P; Javrushyan, H; Karapetyan, A; Koss-Mikołajczyk, I; Koziara, Z; Kuczyńska, M; Kusznierewicz, B; Maloyan, A; Petrosyan, G; Sahakyan, N1
Fields, L; Kim, EJ; Li, L; Liu, F; Ma, M; Miles, HN; Xu, W1
Deng, G; Hussain, A; Kang, X; Xie, L1
Chen, Q; Chen, Y; Hu, Q; Li, A; Li, J; Li, L; Shen, N; Zhang, N1
Bernhardt, G; Keller, M; Kuwert, T; Maschauer, S; Ott, JJ; Prante, O1
Avtandilyan, N; Grigoryan, A; Javrushyan, H; Mamikonyan, A; Trchounian, A1
Bäcker, S; Bier, D; Gago, F; Gigante, A; Hu, X; Knauer, S; Ottmann, C; Sánchez-Murcia, PA; Schmuck, C; Sijbesma, E1
Hakimelahi, A; Kassaee, SM; Mahmoodi, M; Sharifi, R1
Duan, D; Feng, J; Huang, B; Ji, J; Li, L; Li, Z; Lin, C; Lin, L; Liu, J; Liu, L; Lu, J; Zhang, N; Zhang, Y1
Gao, J; Guo, B; Hu, C; Long, H; Shu, C; Wang, X; Yang, F; Zha, H; Zhou, L; Zhu, B1
Hwang, JW; Hwang, KT; Jang, CY; Kim, NH; Kim, S; Kim, YA; Kim, YK; Myung, N; Park, JE1
Beato, M; Sharma, P1
Fernando, V; Furuta, S; Letson, J; Sharma, V; Walia, Y; Zheng, X1
David, Y; Osunsade, A; Zheng, Q1
Abbasi, S; Abd El-Wahab, A; Abdallah, M; Abebe, G; Aca-Aca, G; Adama, S; Adefegha, SA; Adidigue-Ndiome, R; Adiseshaiah, P; Adrario, E; Aghajanian, C; Agnese, W; Ahmad, A; Ahmad, I; Ahmed, MFE; Akcay, OF; Akinmoladun, AC; Akutagawa, T; Alakavuklar, MA; Álava-Rabasa, S; Albaladejo-Florín, MJ; Alexandra, AJE; Alfawares, R; Alferiev, IS; Alghamdi, HS; Ali, I; Allard, B; Allen, JD; Almada, E; Alobaid, A; Alonso, GL; Alqahtani, YS; Alqarawi, W; Alsaleh, H; Alyami, BA; Amaral, BPD; Amaro, JT; Amin, SAW; Amodio, E; Amoo, ZA; Andia Biraro, I; Angiolella, L; Anheyer, D; Anlay, DZ; Annex, BH; Antonio-Aguirre, B; Apple, S; Arbuznikov, AV; Arinsoy, T; Armstrong, DK; Ash, S; Aslam, M; Asrie, F; Astur, DC; Atzrodt, J; Au, DW; Aucoin, M; Auerbach, EJ; Azarian, S; Ba, D; Bai, Z; Baisch, PRM; Balkissou, AD; Baltzopoulos, V; Banaszewski, M; Banerjee, S; Bao, Y; Baradwan, A; Barandika, JF; Barger, PM; Barion, MRL; Barrett, CD; Basudan, AM; Baur, LE; Baz-Rodríguez, SA; Beamer, P; Beaulant, A; Becker, DF; Beckers, C; Bedel, J; Bedlack, R; Bermúdez de Castro, JM; Berry, JD; Berthier, C; Bhattacharya, D; Biadgo, B; Bianco, G; Bianco, M; Bibi, S; Bigliardi, AP; Billheimer, D; Birnie, DH; Biswas, K; Blair, HC; Bognetti, P; Bolan, PJ; Bolla, JR; Bolze, A; Bonnaillie, P; Borlimi, R; Bórquez, J; Bottari, NB; Boulleys-Nana, JR; Brighetti, G; Brodeur, GM; Budnyak, T; Budnyk, S; Bukirwa, VD; Bulman, DM; Burm, R; Busman-Sahay, K; Butcher, TW; Cai, C; Cai, H; Cai, L; Cairati, M; Calvano, CD; Camacho-Ordóñez, A; Camela, E; Cameron, T; Campbell, BS; Cansian, RL; Cao, Y; Caporale, AS; Carciofi, AC; Cardozo, V; Carè, J; Carlos, AF; Carozza, R; Carroll, CJW; Carsetti, A; Carubelli, V; Casarotta, E; Casas, M; Caselli, G; Castillo-Lora, J; Cataldi, TRI; Cavalcante, ELB; Cavaleiro, A; Cayci, Z; Cebrián-Tarancón, C; Cedrone, E; Cella, D; Cereda, C; Ceretti, A; Ceroni, M; Cha, YH; Chai, X; Chang, EF; Chang, TS; Chanteux, H; Chao, M; Chaplin, BP; Chaturvedi, S; Chaturvedi, V; Chaudhary, DK; Chen, A; Chen, C; Chen, HY; Chen, J; Chen, JJ; Chen, K; Chen, L; Chen, Q; Chen, R; Chen, SY; Chen, TY; Chen, WM; Chen, X; Chen, Y; Cheng, G; Cheng, GJ; Cheng, J; Cheng, YH; Cheon, HG; Chew, KW; Chhoker, S; Chiu, WN; Choi, ES; Choi, MJ; Choi, SD; Chokshi, S; Chorny, M; Chu, KI; Chu, WJ; Church, AL; Cirrincione, A; Clamp, AR; Cleff, MB; Cohen, M; Coleman, RL; Collins, SL; Colombo, N; Conduit, N; Cong, WL; Connelly, MA; Connor, J; Cooley, K; Correa Ramos Leal, I; Cose, S; Costantino, C; Cottrell, M; Cui, L; Cundall, J; Cutaia, C; Cutler, CW; Cuypers, ML; da Silva Júnior, FMR; Dahal, RH; Damiani, E; Damtie, D; Dan-Li, W; Dang, Z; Dasa, SSK; Davin, A; Davis, DR; de Andrade, CM; de Jong, PL; de Oliveira, D; de Paula Dorigam, JC; Dean, A; Deepa, M; Delatour, C; Dell'Aiera, S; Delley, MF; den Boer, RB; Deng, L; Deng, Q; Depner, RM; Derdau, V; Derici, U; DeSantis, AJ; Desmarini, D; Diffo-Sonkoue, L; Divizia, M; Djenabou, A; Djordjevic, JT; Dobrovolskaia, MA; Domizi, R; Donati, A; Dong, Y; Dos Santos, M; Dos Santos, MP; Douglas, RG; Duarte, PF; Dullaart, RPF; Duscha, BD; Edwards, LA; Edwards, TE; Eichenwald, EC; El-Baba, TJ; Elashiry, M; Elashiry, MM; Elashry, SH; Elliott, A; Elsayed, R; Emerson, MS; Emmanuel, YO; Emory, TH; Endale-Mangamba, LM; Enten, GA; Estefanía-Fernández, K; Estes, JD; Estrada-Mena, FJ; Evans, S; Ezra, L; Faria de, RO; Farraj, AK; Favre, C; Feng, B; Feng, J; Feng, L; Feng, W; Feng, X; Feng, Z; Fernandes, CLF; Fernández-Cuadros, ME; Fernie, AR; Ferrari, D; Florindo, PR; Fong, PC; Fontes, EPB; Fontinha, D; Fornari, VJ; Fox, NP; Fu, Q; Fujitaka, Y; Fukuhara, K; Fumeaux, T; Fuqua, C; Fustinoni, S; Gabbanelli, V; Gaikwad, S; Gall, ET; Galli, A; Gancedo, MA; Gandhi, MM; Gao, D; Gao, K; Gao, M; Gao, Q; Gao, X; Gao, Y; Gaponenko, V; Garber, A; Garcia, EM; García-Campos, C; García-Donas, J; García-Pérez, AL; Gasparri, F; Ge, C; Ge, D; Ge, JB; Ge, X; George, I; George, LA; Germani, G; Ghassemi Tabrizi, S; Gibon, Y; Gillent, E; Gillies, RS; Gilmour, MI; Goble, S; Goh, JC; Goiri, F; Goldfinger, LE; Golian, M; Gómez, MA; Gonçalves, J; Góngora-García, OR; Gonul, I; González, MA; Govers, TM; Grant, PC; Gray, EH; Gray, JE; Green, MS; Greenwald, I; Gregory, MJ; Gretzke, D; Griffin-Nolan, RJ; Griffith, DC; Gruppen, EG; Guaita, A; Guan, P; Guan, X; Guerci, P; Guerrero, DT; Guo, M; Guo, P; Guo, R; Guo, X; Gupta, J; Guz, G; Hajizadeh, N; Hamada, H; Haman-Wabi, AB; Han, TT; Hannan, N; Hao, S; Harjola, VP; Harmon, M; Hartmann, MSM; Hartwig, JF; Hasani, M; Hawthorne, WJ; Haykal-Coates, N; Hazari, MS; He, DL; He, P; He, SG; Héau, C; Hebbar Kannur, K; Helvaci, O; Heuberger, DM; Hidalgo, F; Hilty, MP; Hirata, K; Hirsch, A; Hoffman, AM; Hoffmann, JF; Holloway, RW; Holmes, RK; Hong, S; Hongisto, M; Hopf, NB; Hörlein, R; Hoshino, N; Hou, Y; Hoven, NF; Hsieh, YY; Hsu, CT; Hu, CW; Hu, JH; Hu, MY; Hu, Y; Hu, Z; Huang, C; Huang, D; Huang, DQ; Huang, L; Huang, Q; Huang, R; Huang, S; Huang, SC; Huang, W; Huang, Y; Huffman, KM; Hung, CH; Hung, CT; Huurman, R; Hwang, SM; Hyun, S; Ibrahim, AM; Iddi-Faical, A; Immordino, P; Isla, MI; Jacquemond, V; Jacques, T; Jankowska, E; Jansen, JA; Jäntti, T; Jaque-Fernandez, F; Jarvis, GA; Jatt, LP; Jeon, JW; Jeong, SH; Jhunjhunwala, R; Ji, F; Jia, X; Jia, Y; Jian-Bo, Z; Jiang, GD; Jiang, L; Jiang, W; Jiang, WD; Jiang, Z; Jiménez-Hoyos, CA; Jin, S; Jobling, MG; John, CM; John, T; Johnson, CB; Jones, KI; Jones, WS; Joseph, OO; Ju, C; Judeinstein, P; Junges, A; Junnarkar, M; Jurkko, R; Kaleka, CC; Kamath, AV; Kang, X; Kantsadi, AL; Kapoor, M; Karim, Z; Kashuba, ADM; Kassa, E; Kasztura, M; Kataja, A; Katoh, T; Kaufman, JS; Kaupp, M; Kehinde, O; Kehrenberg, C; Kemper, N; Kerr, CW; Khan, AU; Khan, MF; Khan, ZUH; Khojasteh, SC; Kilburn, S; Kim, CG; Kim, DU; Kim, DY; Kim, HJ; Kim, J; Kim, OH; Kim, YH; King, C; Klein, A; Klingler, L; Knapp, AK; Ko, TK; Kodavanti, UP; Kolla, V; Kong, L; Kong, RY; Kong, X; Kore, S; Kortz, U; Korucu, B; Kovacs, A; Krahnert, I; Kraus, WE; Kuang, SY; Kuehn-Hajder, JE; Kurz, M; Kuśtrowski, P; Kwak, YD; Kyttaris, VC; Laga, SM; Laguerre, A; Laloo, A; Langaro, MC; Langham, MC; Lao, X; Larocca, MC; Lassus, J; Lattimer, TA; Lazar, S; Le, MH; Leal, DB; Leal, M; Leary, A; Ledermann, JA; Lee, JF; Lee, MV; Lee, NH; Leeds, CM; Leeds, JS; Lefrandt, JD; Leicht, AS; Leonard, M; Lev, S; Levy, K; Li, B; Li, C; Li, CM; Li, DH; Li, H; Li, J; Li, L; Li, LJ; Li, N; Li, P; Li, T; Li, X; Li, XH; Li, XQ; Li, XX; Li, Y; Li, Z; Li, ZY; Liao, YF; Lin, CC; Lin, MH; Lin, Y; Ling, Y; Links, TP; Lira-Romero, E; Liu, C; Liu, D; Liu, H; Liu, J; Liu, L; Liu, LP; Liu, M; Liu, T; Liu, W; Liu, X; Liu, XH; Liu, Y; Liuwantara, D; Ljumanovic, N; Lobo, L; Lokhande, K; Lopes, A; Lopes, RMRM; López-Gutiérrez, JC; López-Muñoz, MJ; López-Santamaría, M; Lorenzo, C; Lorusso, D; Losito, I; Lu, C; Lu, H; Lu, HZ; Lu, SH; Lu, SN; Lu, Y; Lu, ZY; Luboga, F; Luo, JJ; Luo, KL; Luo, Y; Lutomski, CA; Lv, W; M Piedade, MF; Ma, J; Ma, JQ; Ma, JX; Ma, N; Ma, P; Ma, S; Maciel, M; Madureira, M; Maganaris, C; Maginn, EJ; Mahnashi, MH; Maierhofer, M; Majetschak, M; Malla, TR; Maloney, L; Mann, DL; Mansuri, A; Marelli, E; Margulis, CJ; Marrella, A; Martin, BL; Martín-Francés, L; Martínez de Pinillos, M; Martínez-Navarro, EM; Martinez-Quintanilla Jimenez, D; Martínez-Velasco, A; Martínez-Villaseñor, L; Martinón-Torres, M; Martins, BA; Massongo, M; Mathew, AP; Mathews, D; Matsui, J; Matsumoto, KI; Mau, T; Maves, RC; Mayclin, SJ; Mayer, JM; Maynard, ND; Mayr, T; Mboowa, MG; McEvoy, MP; McIntyre, RC; McKay, JA; McPhail, MJW; McVeigh, AL; Mebazaa, A; Medici, V; Medina, DN; Mehmood, T; Mei-Li, C; Melku, M; Meloncelli, S; Mendes, GC; Mendoza-Velásquez, C; Mercadante, R; Mercado, MI; Merenda, MEZ; Meunier, J; Mi, SL; Michels, M; Mijatovic, V; Mikhailov, V; Milheiro, SA; Miller, DC; Ming, F; Mitsuishi, M; Miyashita, T; Mo, J; Mo, S; Modesto-Mata, M; Moeller, S; Monte, A; Monteiro, L; Montomoli, J; Moore, EE; Moore, HB; Moore, PK; Mor, MK; Moratalla-López, N; Moratilla Lapeña, L; Moreira, R; Moreno, MA; Mörk, AC; Morton, M; Mosier, JM; Mou, LH; Mougharbel, AS; Muccillo-Baisch, AL; Muñoz-Serrano, AJ; Mustafa, B; Nair, GM; Nakanishi, I; Nakanjako, D; Naraparaju, K; Nawani, N; Neffati, R; Neil, EC; Neilipovitz, D; Neira-Borrajo, I; Nelson, MT; Nery, PB; Nese, M; Nguyen, F; Nguyen, MH; Niazy, AA; Nicolaï, J; Nogueira, F; Norbäck, D; Novaretti, JV; O'Donnell, T; O'Dowd, A; O'Malley, DM; Oaknin, A; Ogata, K; Ohkubo, K; Ojha, M; Olaleye, MT; Olawande, B; Olomo, EJ; Ong, EWY; Ono, A; Onwumere, J; Ortiz Bibriesca, DM; Ou, X; Oza, AM; Ozturk, K; Özütemiz, C; Palacio-Pastrana, C; Palaparthi, A; Palevsky, PM; Pan, K; Pantanetti, S; Papachristou, DJ; Pariani, A; Parikh, CR; Parissis, J; Paroul, N; Parry, S; Patel, N; Patel, SM; Patel, VC; Pawar, S; Pefura-Yone, EW; Peixoto Andrade, BCO; Pelepenko, LE; Peña-Lora, D; Peng, S; Pérez-Moro, OS; Perez-Ortiz, AC; Perry, LM; Peter, CM; Phillips, NJ; Phillips, P; Pia Tek, J; Piner, LW; Pinto, EA; Pinto, SN; Piyachaturawat, P; Poka-Mayap, V; Polledri, E; Poloni, TE; Ponessa, G; Poole, ST; Post, AK; Potter, TM; Pressly, BB; Prouty, MG; Prudêncio, M; Pulkki, K; Pupier, C; Qian, H; Qian, ZP; Qiu, Y; Qu, G; Rahimi, S; Rahman, AU; Ramadan, H; Ramanna, S; Ramirez, I; Randolph, GJ; Rasheed, A; Rault, J; Raviprakash, V; Reale, E; Redpath, C; Rema, V; Remucal, CK; Remy, D; Ren, T; Ribeiro, LB; Riboli, G; Richards, J; Rieger, V; Rieusset, J; Riva, A; Rivabella Maknis, T; Robbins, JL; Robinson, CV; Roche-Campo, F; Rodriguez, R; Rodríguez-de-Cía, J; Rollenhagen, JE; Rosen, EP; Rub, D; Rubin, N; Rubin, NT; Ruurda, JP; Saad, O; Sabell, T; Saber, SE; Sabet, M; Sadek, MM; Saejio, A; Salinas, RM; Saliu, IO; Sande, D; Sang, D; Sangenito, LS; Santos, ALSD; Sarmiento Caldas, MC; Sassaroli, S; Sassi, V; Sato, J; Sauaia, A; Saunders, K; Saunders, PR; Savarino, SJ; Scambia, G; Scanlon, N; Schetinger, MR; Schinkel, AFL; Schladweiler, MC; Schofield, CJ; Schuepbach, RA; Schulz, J; Schwartz, N; Scorcella, C; Seeley, J; Seemann, F; Seinige, D; Sengoku, T; Seravalli, J; Sgromo, B; Shaheen, MY; Shan, L; Shanmugam, S; Shao, H; Sharma, S; Shaw, KJ; Shen, BQ; Shen, CH; Shen, P; Shen, S; Shen, Y; Shen, Z; Shi, J; Shi-Li, L; Shimoda, K; Shoji, Y; Shun, C; Silva, MA; Silva-Cardoso, J; Simas, NK; Simirgiotis, MJ; Sincock, SA; Singh, MP; Sionis, A; Siu, J; Sivieri, EM; Sjerps, MJ; Skoczen, SL; Slabon, A; Slette, IJ; Smith, MD; Smith, S; Smith, TG; Snapp, KS; Snow, SJ; Soares, MCF; Soberman, D; Solares, MD; Soliman, I; Song, J; Sorooshian, A; Sorrell, TC; Spinar, J; Staudt, A; Steinhart, C; Stern, ST; Stevens, DM; Stiers, KM; Stimming, U; Su, YG; Subbian, V; Suga, H; Sukhija-Cohen, A; Suksamrarn, A; Suksen, K; Sun, J; Sun, M; Sun, P; Sun, W; Sun, XF; Sun, Y; Sundell, J; Susan, LF; Sutjarit, N; Swamy, KV; Swisher, EM; Sykes, C; Takahashi, JA; Talmor, DS; Tan, B; Tan, ZK; Tang, L; Tang, S; Tanner, JJ; Tanwar, M; Tarazi, Z; Tarvasmäki, T; Tay, FR; Teketel, A; Temitayo, GI; Thersleff, T; Thiessen Philbrook, H; Thompson, LC; Thongon, N; Tian, B; Tian, F; Tian, Q; Timothy, AT; Tingle, MD; Titze, IR; Tolppanen, H; Tong, W; Toyoda, H; Tronconi, L; Tseng, CH; Tu, H; Tu, YJ; Tung, SY; Turpault, S; Tuynman, JB; Uemoto, AT; Ugurlu, M; Ullah, S; Underwood, RS; Ungell, AL; Usandizaga-Elio, I; Vakonakis, I; van Boxel, GI; van den Beucken, JJJP; van der Boom, T; van Slegtenhorst, MA; Vanni, JR; Vaquera, A; Vasconcellos, RS; Velayos, M; Vena, R; Ventura, G; Verso, MG; Vincent, RP; Vitale, F; Vitali, S; Vlek, SL; Vleugels, MPH; Volkmann, N; Vukelic, M; Wagner Mackenzie, B; Wairagala, P; Waller, SB; Wan, J; Wan, MT; Wan, Y; Wang, CC; Wang, H; Wang, J; Wang, JF; Wang, K; Wang, L; Wang, M; Wang, S; Wang, WM; Wang, X; Wang, Y; Wang, YD; Wang, YF; Wang, Z; Wang, ZG; Warriner, K; Weberpals, JI; Weerachayaphorn, J; Wehrli, FW; Wei, J; Wei, KL; Weinheimer, CJ; Weisbord, SD; Wen, S; Wendel Garcia, PD; Williams, JW; Williams, R; Winkler, C; Wirman, AP; Wong, S; Woods, CM; Wu, B; Wu, C; Wu, F; Wu, P; Wu, S; Wu, Y; Wu, YN; Wu, ZH; Wurtzel, JGT; Xia, L; Xia, Z; Xia, ZZ; Xiao, H; Xie, C; Xin, ZM; Xing, Y; Xing, Z; Xu, S; Xu, SB; Xu, T; Xu, X; Xu, Y; Xue, L; Xun, J; Yaffe, MB; Yalew, A; Yamamoto, S; Yan, D; Yan, H; Yan, S; Yan, X; Yang, AD; Yang, E; Yang, H; Yang, J; Yang, JL; Yang, K; Yang, M; Yang, P; Yang, Q; Yang, S; Yang, W; Yang, X; Yang, Y; Yao, JC; Yao, WL; Yao, Y; Yaqub, TB; Ye, J; Ye, W; Yen, CW; Yeter, HH; Yin, C; Yip, V; Yong-Yi, J; Yu, HJ; Yu, MF; Yu, S; Yu, W; Yu, WW; Yu, X; Yuan, P; Yuan, Q; Yue, XY; Zaia, AA; Zakhary, SY; Zalwango, F; Zamalloa, A; Zamparo, P; Zampini, IC; Zani, JL; Zeitoun, R; Zeng, N; Zenteno, JC; Zepeda-Palacio, C; Zhai, C; Zhang, B; Zhang, G; Zhang, J; Zhang, K; Zhang, Q; Zhang, R; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, B; Zhao, D; Zhao, G; Zhao, H; Zhao, Q; Zhao, R; Zhao, S; Zhao, T; Zhao, X; Zhao, XA; Zhao, Y; Zhao, Z; Zheng, Z; Zhi-Min, G; Zhou, CL; Zhou, HD; Zhou, J; Zhou, W; Zhou, XQ; Zhou, Z; Zhu, C; Zhu, H; Zhu, L; Zhu, Y; Zitzmann, N; Zou, L; Zou, Y1
Huang, B; Li, H; Li, L; Liu, DX; Liu, J; Liu, L; Liu, X; Liu, Y; Lu, J; Peng, L; Wang, G; Wang, Y; Zhang, L; Zhang, Y1
Anderson, JN; Bao, Y; Bartlett, JR; Bissonnette, S; Briant, AR; Carcel, C; Chan, K; Chen, H; Chen, L; Cheng, C; Chrétien, M; Conway Fitzgerald, A; Cyr, Y; Du, Y; El-Sayed, YY; Endo, T; Faraj, M; Fujimoto, K; Girsen, A; Goto, H; Hashimoto, D; Hayasaka, K; Hayase, E; Herrmann, N; Hidaka, D; Holst, JJ; Igbinosa, I; Iijima, H; Jeandidier, N; Jeong, DY; Jeong, GT; Joubert, M; Kagawa, I; Kahata, K; Kaushik, LK; Kim, SK; Kim, SR; Kuang, Y; Laird, M; Lamantia, V; Li, P; Li, Y; Li, Z; Lindsay, SE; Liu, X; Loizon, E; Lu, Z; Lyell, DJ; Ma, J; Magnani, CJ; Mahalingam, AK; Mandal, N; Mayer, G; Michimata, R; Ngo Sock, ET; Okada, K; Onozawa, M; Opigez, V; Palanisamy, M; Parienti, JJ; Park, YR; Pavlikova, B; Peyro Saint Paul, L; Ramsahye, N; Reyes, GA; Reznik, Y; Richardson, MT; Samo, IA; Sarkar, R; Shendge, AK; Shimizu, C; Shiratori, S; Steinberg, JR; Sugita, J; Sukwong, P; Sun, X; Sunagoya, K; Sunwoo, IY; Svendsen, B; Tang, L; Tang, Z; Teshima, T; Totée, C; Turner, BE; Unno, M; Vidal, H; Wang, C; Wang, M; Wang, S; Wang, X; Wang, Z; Wassef, H; Weeks, BT; Wong Chi Man, M; Xu, C; Xu, W; Yamamoto, S; Yu, H; Zhang, WY; Zhang, X; Zhong, Y1
Al-Dhabi, NA; Arasu, MV; Arockiaraj, J; Arshad, A; Charles, S; Madhavan, T; Mala, K; Munusamy-Ramanujam, G; Saraswathi, NT; Singh, P1
Da Costa, RSS; Esteves, VF; Koifman, RJ; Koifman, S; Schilling, MPR; Silva, IFD1
Bel'skaya, LV; Kosenok, VK; Sarf, EA1
Chen, L; da Silva, SR; Gao, SJ; Ju, E; Li, T; Wang, X; Wei, S; Zhang, X1
Gao, X; He, YH; Hu, GS; Huang, HH; Huang, MF; Li, WJ; Lin, YA; Liu, W; Peng, BL; Ran, T; Xie, BL; Yang, JJ; Ye, F; Zhu, HH1
Cao, D; Ding, H; Hou, J; Huang, B; Lin, C; Liu, J; Liu, L; Liu, X; Liu, Y; Lu, J; Wang, G; Zhang, N; Zhang, X; Zhang, Y1
Irfandi, R; Prihantono, P; Raya, I1
Ball, LE; Brobbey, C; Gan, W; Liu, L; Olsen, SK; Ostrowski, MC; Palanisamy, V; Yin, S1
Fan, B; Gao, Z; Huang, W; Jin, H; Jin, M; Kang, L; Sun, P; Wang, QM1
Coon, JJ; Hebert, AS; Kwiecien, NW; Liu, F; Shishkova, E; Xu, W; Zeng, H1
Lenihan, DJ1
Bradbury, A; Carver, JR; Clark, A; DeMichele, A; Domchek, S; Finkelman, BS; Fox, K; Ky, B; Matro, J; Narayan, H; Narayan, V; Putt, M; Shah, P; Tang, WHW; Wang, L; Wang, T1
Allasia, A; Deutz, NEP; Engelen, MPKJ; Klimberg, VS1
Barber, DL; Hernandez, RD; Jacobson, MP; Ruiz, DG; Strauli, NB; Szpiech, ZA; White, KA1
Fogel, J; Obiagwu, C; Verma, S1
Anastasiou, M; Antonopoulos, AS; Bamias, A; Dimopoulos, MA; Oikonomou, E; Psaltopoulou, T; Siasos, G; Tousoulis, D; Zagouri, F1
Finkelman, BS; Ky, B; Putt, M1
Chen, H; Liu, YB; Ngernyuang, N; Oh, D; Schwartz, LM; Shao, R; Yan, W1
Che, Y; Duan, X; Gao, H; Guo, W; Huang, J; Huang, T; Jin, Y; Lei, L; Li, Y; Ma, H; Ren, W; Xia, X; Zhai, T1
Barlow, D; Frazier, K; Greenstein, I; Harding, L; Mohan, S; Ng, C; Nguyen, G; Patel, S1
Azadbakht, M; Jahani, M; Mansouri, K; Rasouli, H; Rezazadeh, D; Salari, N; Yarani, R1
Beato, M; Carbonell-Caballero, J; Di Vona, C; Eick, D; Fernandez-Fuentes, N; Le Dily, F; Lioutas, A; Oliva, B; Quilez, J; Schüller, R; Sharma, P; Wright, RHG1
Chlopicki, S; Jasztal, A; Kij, A; Kus, K; Stojak, M; Walczak, M; Zakrzewska, A1
Dowhan, DH; Muscat, GEO; Wang, SM1
Labhasetwar, V; Lu, S; Morris, VB1
Cheng, MB; Fan, XZ; Liu, LM; Sun, WZ; Xu, YL; Zhang, Y1
Bala, A; Panditharadyula, SS1
Cortez, V; Mann, M; Vadlamudi, R1
Ferrari, M; Gu, J; Guo, X; Kim, HC; Liu, X; Mai, J; Mao, ZW; Mu, C; Qin, G; Shen, H; Shen, J; Wolfram, J; Xia, X; Xu, R; Yang, Y1
Avliyakulov, NK; Braga, M; Chaudhuri, G; Haykinson, MJ; Martinez, L; Parveen, M; Pervin, S; Singh, R; Singh, V1
Corbo, L; Hussein, N; Le Romancer, M; Poulard, C; Rambaud, J1
Ann, DK; Chen, YR; Chu, CY; Forman, HJ; Gaur, S; Huang, J; Kung, HJ; Liu, X; Qiu, F; Shen, LJ; Xu, J; Yen, Y; Zhang, H; Zheng, S1
Chung, HH; Lin, VC; Sun, Y; Woo, AR1
Geng, D; Sun, D; Zhang, L; Zhang, W1
Chen, WC; Cho, CY; Hsu, HP; Huang, HL; Hung, YH; Lai, MD; Wang, CY1
Bahar, I; Fujita, N; Gamper, A; Gur, M; Hu, D; Hung, MC; Lan, L; Wan, Y; Zhou, Z1
Jheng, PR; Lu, KY; Mi, FL; Yu, SH1
Geck, RC; Toker, A1
Aldashev, AA; Asambaeva, DA; Isakova, ZhT; Makieva, KB; Sultangazieva, BB1
Cao, XL; Gao, JX; Li, LF; Liu, N; Liu, SS; Sun, L; Xia, WY; Xiu, P; Zhao, SH1
Chen, H; Gupta, V; Lorton, B; Shechter, D1
Harding, L; Mohan, S; Moua, N1
Alshetaiwi, H; Bossmann, SH; Malalasekera, AP; McLaurin, EJ; Ortega, R; Samarakoon, TN; Shrestha, TB; Troyer, DL; Udukala, DN; Wang, H; Yapa, AS1
Cao, Y; Gao, Y; Guo, S; Hu, L; Hu, X; Jing, F; Jing, Y; Wang, Y; Xu, M; Zhang, Y; Zhu, Z2
Azadbakht, M; Jahani, M; Mansouri, K; Norooznezhad, F1
Abdelmagid, SA; Too, CK1
Amadori, D; Bonafe, M; Brigliadori, G; Fabbri, F; Gusolfino, D; Massa, I; Passardi, A; Ricci, M; Rosetti, M; Sansone, P; Storci, G; Tesei, A; Ulivi, P; Vannini, I; Zoli, W1
Bouchekioua-Bouzaghou, K; Corbo, L; Gobert-Gosse, S; Goddard, S; Le Romancer, M; Leconte, N; Robin-Lespinasse, Y; Sentis, S; Treilleux, I1
Bucholtz, KM; Kacsoh, B; Mack, VL; Sun, J; Thomas, JL1
Anyanwu, SN; Bunker, CH; Ezeome, ER; Ferrell, RE; Garte, SJ; Kuller, LH; Okobia, MN; Taioli, E; Uche, EE; Zmuda, JM1
Graczyk, A; Kasprzycka-Guttman, T; Misiewicz-Krzemińska, I; Skupińska, K1
Bizarro, S; Castro, F; Cerveira, N; Henrique, R; Peixoto, A; Pereira, D; Pinheiro, M; Rocha, P; Rodrigues, H; Santos, C; Soares, MJ; Teixeira, MR; Vega, A1
Büssemaker, E; Hagedorn, C; Hausberg, M; Hillebrand, U; Kliche, K; Lang, D; Oberleithner, H; Pavenstädt, H; Reuter, S; Stock, CM; Telgmann, RG1
Chang, Y; Liang, D; Liu, Z; Qi, R; Song, T; Sun, X; Vogel, U; Yin, J; Yue, L1
Andò, S; Barone, I; Beyer, A; Corona-Rodriguez, A; Cui, Y; Fuqua, SA; Giordano, C; Herynk, MH; Selever, J1
Rieber, M; Strasberg Rieber, M1
Belyavskaya, VA; Cherdyntseva, NV; Denisov, EV; Litvyakov, NV; Malinovskaya, EA; Slonimskaya, EM; Stegniy, VN; Voevoda, MI1
Chakosari, RJ; Kazemi, M; Salehi, Z1
Cavaillès, V; Corbo, L; Jalaguier, S; Le Romancer, M; Sentis, S; Teyssier, C1
Benner, A; Burwinkel, B; Hahn, M; Lichter, P; Marmé, F; Schneeweiss, A; Sinn, P; Sohn, C; Werft, W1
Casimiro, MC; Chiavarina, B; Flomenberg, N; Frank, PG; Howell, A; Lisanti, MP; Martinez-Outschoorn, UE; Migneco, G; Pavlides, S; Pestell, RG; Sotgia, F; Tsirigos, A; Wang, C; Whitaker-Menezes, D1
Abdelmagid, SA; McDonald, WJ; Rickard, JA; Thomas, LN; Too, CK1
Haramoto, M; Horibe, T; Kawakami, K; Kohno, M; Ohara, K; Tada, N1
Aloj, SM; Chiaviello, A; Paciello, I; Palumbo, G; Veneziani, BM1
Padma, T; Raghunadharao, D; Rao, DN; Sailaja, K; Surekha, D; Vishnupriya, S1
Akita, N; Asanuma, K; Asanuma, Y; Hayashi, T; Matsumine, A; Okamoto, T; Sudo, A; Uchida, A; Wakabayashi, H; Yoshikawa, T1
Kim, PH; Kim, SW; Nam, HY; Nam, K1
Bernhardt, G; Buschauer, A; Keller, M; Lopuch, M; Memminger, M; Pop, N; von Angerer, E1
Chaudhuri, G; Pervin, S; Singh, R2
Andersen, TI; Bregård, A; Bukholm, IR; Børresen-Dale, AL; Langerød, A; Lothe, RA; Lønning, PE; Meling, GI; Rognum, TO1
Barbi, C; Bonafé, M; Ceccarelli, C; Farabegoli, F; Franceschi, C; Marzi, E; Olivieri, F; Santini, D; Storci, G; Taffurelli, M; Trapassi, C1
Hamajima, N; Hirose, K; Huang, XE; Iwata, H; Katsuda, N; Matsuo, K; Miura, S; Mizutani, M; Tajima, K; Tokudome, S; Xiang, J1
Radisavljevic, Z1
Alqawi, O; Bates, S; Georges, E1
Caso, G; Eremin, O; Garlick, PJ; McMillan, ND; McNurlan, MA1
Miyoshi, Y; Noguchi, S; Noma, C; Taguchi, T; Tamaki, Y1
Balakrishnan, L; Janvilisri, T; Shahi, S; van Veen, HW; Venter, H1
De León, DD; Faridi, JS; Mohan, S1
Cao, C; Kufe, D; Leng, Y; Li, P; Li, Y; Ma, Q1
Dejong, CH; Deutz, NE; Fearon, KC; Luiking, YC; Vissers, YL; von Meyenfeldt, MF1
Finley, RL; Li, X; Meng, Y; Reddy, N; Sakr, W; Sheng, S; Yang, H; Yin, S1
Bange, J; Knyazev, P; Stadler, CR; Ullrich, A1
Gao, J; Hu, Z; Jin, G; Liu, J; Qing, J; Shen, H; Wang, S; Wang, X; Zhai, X1
Ambrosone, CB; Chang-Claude, J; Haase, W; Helmbold, I; Kropp, S; Popanda, O; Sautter-Bihl, ML; Schmezer, P; Tan, XL; von Fournier, D; Wenz, F1
Azuma, H; Ehata, S; Horie, S; Imamura, T; Inamoto, T; Itoh, Y; Katsuoka, Y; Kiyama, S; Kiyama, Y; Maruyama, O; Miyazaki, H; Miyazono, K; Otsuki, Y; Sakamoto, T; Takahara, S; Ubai, T; Watabe, T1
Beloussow, K; Shen, LJ; Shen, WC1
Bange, J; Harbeck, N; Hoefler, H; Kates, R; Kiechle, M; Kriner, M; Nahrig, J; Streit, S; Thussbas, C; Ullrich, A; Ulm, K1
Hoffman, RM; Li, S; Li, X; Ma, H; Tan, X; Yang, M; Yang, Z; Zhao, M1
Bergamaschi, D; Bisso, A; Breyssens, H; Crook, T; Del Sal, G; Gasco, M; Lu, X; Samuels, Y; Smith, P; Sullivan, A; Syed, N; Zvelebil, M1
Alexandre, CO; Damin, AP; Damin, DC; Frazzon, AP; Hermes, V; Roehe, A; Zettler, C1
Corbo, L; Kolytcheff, C; Le Romancer, M; Robin-Lespinasse, Y; Rostan, MC; Sentis, S1
Bonafé, M; Chieco, P; Montanaro, L; Pandolfi, S; Sansone, P; Storci, G1
Kim, DH; Kim, JH; Kim, KW; Min, BH; Yu, YS1
Arnold, S; Brown, MA; Buchanan, D; Chenevix-Trench, G; Couch, FJ; Farrugia, DJ; Goldgar, DE; Healey, S; Henderson, BR; Lakhani, SR; Lovelock, PK; Mok, MT; Spurdle, AB; Tavtigian, SV1
Al-Katib, W; Allan, AL; Chambers, AF; Goodale, D; Hedley, BD; Postenka, CO; Schulze, EB; Tuck, AB1
Berghoffer, B; Bodwin, JS; Cho-Chung, YS; Clair, T1
Groom, GV; Paterson, AG; Turkes, A; Webster, DJ1
Bani, D; Bello, MG; Bigazzi, M; Masini, E; Sacchi, TB1
Aberle, H; Bierkamp, C; Heidkämper, C; Lynch, HT; Montagna, M; Natt, E; Serova, O; Torchard, D; Wagner, T; Wirsching, J1
Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, J1
Ah-See, AK; Brittenden, J; Eremin, O; Gilbert, F; Heys, SD; Hutcheon, AW; McKean, M; Miller, I; Needham, G; Sarkar, TK1
Abbondanza, C; Armetta, I; Medici, N; Molinari, AM; Moncharmont, B; Napolitano, M; Nigro, V; Puca, AA; Puca, GA; Schiavulli, M1
Ah-See, Ak; Ashby, J; Brittenden, J; Eremin, O; Heys, SD; Park, KG; Ross, C1
Balbín, M; Ferrando, AA; Fueyo, A; Hannon, GJ; López-Otín, C; Pendás, AM; Vizoso, F1
Ah-See, AK; Dewar, J; Eremin, O; Heys, SD; Hutcheon, AW; Miller, I; Ogston, K; Sarker, TK; Walker, LG1
Alalami, O; Martin, JH1
Eckelman, WC; John, C; Lang, L; Leyton, J; Moody, TW; Unsworth, E1
Børresen-Dale, AL; Helland, A; Johnsen, H; Langerød, A; Olsen, AO; Skovlund, E1
Bansal, RK; Dai, JL; Kern, SE1
Alfarano, A; Becchis, M; Biglia, N; Coluccia, C; Fazzari, A; Ferrera, P; Fortunati, N; Frairia, R; Ondei, S; Sismondi, P1
Cederbaum, S; Chaudhuri, G; Karimi, A; Pervin, S; Singh, R1
Dokianakis, DN; Papadakis, EN; Spandidos, DA1
Chen, WY; Ramamoorthy, P; Sticca, R; Wagner, TE1
Bell, DW; Garber, JE; Gray, H; Haber, DA; Iglehart, DJ; Kaelin, CM; Lunetta, KL; Marks, JR; Nasser, SM; Polyak, K; Rhei, E; Seth, P1
Chang, CI; Kuo, L; Liao, JC1
Pham, HT; Ruediger, R; Walter, G1
Blagosklonny, MV; Fojo, T; Giannakakou, P; Romanova, LY; Ryan, KM; Vousden, KH1
Chaudhuri, G; Pervin, S; Singh, R; Wu, G1
Bange, J; Cheburkin, Y; Gärtner, S; Harbeck, N; Häring, HU; Höfler, H; Iacobelli, S; Imyanitov, E; Knayzev, P; Knyazeva, T; Müller, S; Prechtl, D; Schmitt, M; Specht, K; Sures, I; Ullrich, A; Wang, H1
Alksne, JF; Lachelin, GC; Yen, SC1
Blessing, K; Eremin, O; Garlick, PJ; Heys, SD; Kelly, P; McNurlan, MA; Park, KG1
Beaupain, R; Coulomb, B; Galle, P; Hindie, E1
Hitch, DC; Kubota, A; Meguid, MM1
Cattran, DC; Chow, S; Roscoe, J1
Lindall, AW; Novelli, E; Theologides, A1
Cui, J; Jiang, S; Li, Y; Liu, Z; Ma, L; Wang, Y; Yin, Q; Yu, H; Zhang, Z1
Chu, B; Hu, L; Li, X; Lin, G; Shi, L; Shi, S; Xu, Q; Ye, L; Zhang, H; Zhang, N; Zhang, X1
Di, X; Dumur, C; Elmore, LW; Gewirtz, DA; Holt, SE1
Schwarz, MA; Snyder, RD1
Calciati, A; Conte, PF; Giaccone, G; Musella, R1
Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P1
Crivellari, D; Franchin, G; Galligioni, E; Grigoletto, E; Talamini, R; Tirelli, U; Trovó, MG; Tumolo, S; Veronesi, A1
Carbone, A; Galligioni, E; Grigoletto, E; Tirelli, U; Trovo, MG; Veronesi, A; Volpe, R1
Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL1
Fornari, FA; Gewirtz, DA; Orr, MS; Randolph, JK1
Cowan, KH; Horton, JK; Nakagawa, M; Schneider, E; Yang, CH1
Bunch, RT; Fornari, FA; Gewirtz, DA; Orr, MS; Povirk, LF; Randolph, JK; Ritke, MK; Yalowich, JC1
Beijnen, JH; Boogerd, W; Nooijen, WJ; van Tellingen, O1
Gewirtz, DA; Jain, PT; Orr, MS; Randolph, JK; Sundaram, S; Watson, NC1
Bianco, C; Ciardiello, F; Damiano, V; Davies, SL; di Isernia, G; Harris, AL; Hickson, ID; North, P; Pepe, S; Tortora, G1
Khodjakov, A; Sánchez-Alcázar, JA; Schneider, E1
Cleveland, JL; Di, YM; Gewirtz, DA; Jain, PT; Magnet, KJ; Orr, MS; Rodriguez-Galindo, C; Yang, C; Yang, H1
Bibeau, F; Cebotaru, C; El Weshi, A; Fadel, C; Fenaux, P; Frayfer, J; Laribi, K; Ribrag, V1
Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P1
Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P1
Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Nielsen, D1
Boas, J; Dombernowsky, P; Engelholm, SA; Hansen, OP; Rasmussen, D1
Carpenter, JT; Cox, EB; Raney, M; Vogel, CL1

Reviews

7 review(s) available for arginine and Breast Cancer

ArticleYear
Peptidyl Arginine Deiminase 2 (PADI2)-Mediated Arginine Citrullination Modulates Transcription in Cancer.
    International journal of molecular sciences, 2020, Feb-17, Volume: 21, Issue:4

    Topics: Animals; Arginine; Arthritis, Rheumatoid; Autoimmune Diseases; Breast Neoplasms; Cell Proliferation; Chromatin; Citrullination; Disease Progression; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunity; Multiple Sclerosis; Protein-Arginine Deiminase Type 2; RNA Polymerase II; Substrate Specificity

2020
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
Epigenetic arginine methylation in breast cancer: emerging therapeutic strategies.
    Journal of molecular endocrinology, 2019, 04-01, Volume: 62, Issue:3

    Topics: Animals; Arginine; Breast Neoplasms; Epigenesis, Genetic; Female; Humans; Methylation

2019
Role of Nuclear Factor Erythroid 2-Related Factor 2 (NRF-2) Mediated Antioxidant Response on the Synergistic Antitumor Effect of L-Arginine and 5-Fluro Uracil (5FU) in Breast Adenocarcinoma.
    Current pharmaceutical design, 2019, Volume: 25, Issue:14

    Topics: Adenocarcinoma; Animals; Antioxidants; Arginine; Breast Neoplasms; Fluorouracil; Humans; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species

2019
Nonessential amino acid metabolism in breast cancer.
    Advances in biological regulation, 2016, Volume: 62

    Topics: Animals; Arginine; Breast Neoplasms; Cysteine; Diet Therapy; Female; Food Deprivation; Glutamic Acid; Glutamine; Glycine; Humans; Metabolic Networks and Pathways; Proline; Serine

2016
Protein arginine methylation in estrogen signaling and estrogen-related cancers.
    Trends in endocrinology and metabolism: TEM, 2010, Volume: 21, Issue:3

    Topics: Animals; Arginine; Breast Neoplasms; Estrogens; Female; Humans; Male; Methylation; Models, Biological; Neoplasms; Protein-Arginine N-Methyltransferases; Receptors, Estrogen; Signal Transduction

2010
Nitric oxide, N omega-hydroxy-L-arginine and breast cancer.
    Nitric oxide : biology and chemistry, 2008, Volume: 19, Issue:2

    Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Cycle Proteins; Cell Proliferation; Female; Humans; Nitric Oxide

2008

Trials

10 trial(s) available for arginine and Breast Cancer

ArticleYear
    Zeitschrift fur Gesundheitswissenschaften = Journal of public health, 2022, Volume: 30, Issue:2

    Topics: 3T3-L1 Cells; A Kinase Anchor Proteins; Acetates; Achilles Tendon; Acute Kidney Injury; Acute Pain; Acyclic Monoterpenes; Adenine Nucleotides; Adhesins, Escherichia coli; Adipocytes; Adipocytes, Brown; Adipogenesis; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adsorption; Adult; Aeromonas hydrophila; Africa; Aged; Aged, 80 and over; Agrobacterium tumefaciens; Air; Air Pollutants; Air Pollution; Air Pollution, Indoor; Algorithms; Alkaloids; Alkynes; Allosteric Regulation; Amines; Amino Acid Sequence; Amino Acids; Amino Acids, Branched-Chain; Aminoisobutyric Acids; Aminopyridines; Amyotrophic Lateral Sclerosis; Anaerobic Threshold; Angiography; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animal Distribution; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Ankle Joint; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Inflammatory Agents; Antibodies, Bacterial; Antifungal Agents; Antimalarials; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antioxidants; Antiretroviral Therapy, Highly Active; Antiviral Agents; Aotidae; Apelin; Apoptosis; Arabidopsis Proteins; Argentina; Arginine; Artemisinins; Arthritis, Experimental; Arthritis, Rheumatoid; Arthroscopy; Aspergillus; Aspergillus niger; Asteraceae; Asthma; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Auditory Cortex; Autoantibodies; Autophagy; Bacteria; Bacterial Infections; Bacterial Proteins; Bacterial Typing Techniques; Base Composition; Base Sequence; Basketball; Beclin-1; Benzhydryl Compounds; Benzimidazoles; Benzo(a)pyrene; Benzofurans; Benzoxazines; Bereavement; beta Catenin; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Betacoronavirus; Betaine; Binding Sites; Biofilms; Biological Assay; Biological Availability; Biological Evolution; Biomarkers; Biomechanical Phenomena; Biopolymers; Biopsy; Bismuth; Blood Glucose; Blood Platelets; Blood Pressure; Body Composition; Body Weight; Bone Marrow; Bone Marrow Cells; Bone Regeneration; Boron; Botrytis; Brain Ischemia; Brain Neoplasms; Brain-Derived Neurotrophic Factor; Brazil; Breast Neoplasms; Breath Tests; Bronchoalveolar Lavage Fluid; Burkholderia; C-Reactive Protein; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcification, Physiologic; Calcium; Calcium Signaling; Calorimetry, Differential Scanning; Cameroon; Camptothecin; Candida; Candida albicans; Capillaries; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carbohydrate Conformation; Carbon; Carbon Dioxide; Carbon Isotopes; Carcinoma, Ovarian Epithelial; Cardiac Output; Cardiomyopathy, Hypertrophic; Cardiotonic Agents; Cardiovascular Diseases; Caregivers; Carps; Case-Control Studies; Catalase; Catalysis; Cats; CD4 Lymphocyte Count; Cell Culture Techniques; Cell Differentiation; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Cellulose; Centrosome; Ceratopogonidae; Chickens; Child; China; Cholera Toxin; Choline; Cholinesterases; Chromatography, High Pressure Liquid; Chromatography, Liquid; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chronic Disease; Cinnamates; Cities; Citrates; Climate Change; Clinical Trials, Phase III as Topic; Coal; Coal Mining; Cohort Studies; Coinfection; Colchicine; Colony Count, Microbial; Colorectal Neoplasms; Coloring Agents; Common Cold; Complement Factor H; Computational Biology; Computer Simulation; Continuous Positive Airway Pressure; Contrast Media; Coordination Complexes; Coronary Artery Bypass; Coronavirus 3C Proteases; Coronavirus Infections; Coronavirus Protease Inhibitors; Corynebacterium glutamicum; Cosmetics; COVID-19; Creatinine; Cross-Sectional Studies; Crotonates; Crystallography, X-Ray; Cues; Culicidae; Culture Media; Curcuma; Cyclopentanes; Cyclopropanes; Cymbopogon; Cystine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Cytokines; Databases, Genetic; Death; Dendritic Cells; Density Functional Theory; Depsides; Diabetes Mellitus, Type 2; Diamond; Diarylheptanoids; Dibenzofurans; Dibenzofurans, Polychlorinated; Diclofenac; Diet; Dietary Carbohydrates; Dietary Supplements; Diffusion Magnetic Resonance Imaging; Dioxins; Diphenylamine; Disease Outbreaks; Disease Susceptibility; Disulfides; Dithiothreitol; Dizocilpine Maleate; DNA Methylation; DNA-Binding Proteins; DNA, Bacterial; Dogs; Dose-Response Relationship, Drug; Double-Blind Method; Doublecortin Protein; Drosophila melanogaster; Droughts; Drug Carriers; Drug Combinations; Drug Delivery Systems; Drug Liberation; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Dust; Dynactin Complex; Dysferlin; Echo-Planar Imaging; Echocardiography; Edaravone; Egypt; Elasticity; Electrodes; Electrolytes; Emodin; Emtricitabine; Endometriosis; Endothelium, Vascular; Endotoxins; Energy Metabolism; Energy Transfer; Enterobacteriaceae; Enterococcus faecalis; Enterotoxigenic Escherichia coli; Environmental Monitoring; Enzyme Inhibitors; Epidemiologic Factors; Epigenesis, Genetic; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Vaccines; Esophageal Neoplasms; Esophagectomy; Esophagogastric Junction; Esterases; Esterification; Ethanol; Ethiopia; Ethnicity; Eucalyptus; Evidence-Based Practice; Exercise; Exercise Tolerance; Extracorporeal Membrane Oxygenation; Family; Fatty Acids; Feedback; Female; Ferric Compounds; Fibrin Fibrinogen Degradation Products; Filtration; Fish Diseases; Flavonoids; Flavonols; Fluorodeoxyglucose F18; Follow-Up Studies; Food Microbiology; Food Preservation; Forests; Fossils; Free Radical Scavengers; Freund's Adjuvant; Fruit; Fungi; Gallium; Gender Identity; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Genes, Bacterial; Genes, Plant; Genetic Predisposition to Disease; Genitalia; Genotype; Glomerulonephritis, IGA; Glottis; Glucocorticoids; Glucose; Glucuronides; Glutathione Transferase; Glycogen Synthase Kinase 3 beta; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Grassland; Guinea Pigs; Half-Life; Head Kidney; Heart Atria; Heart Rate; Heart Septum; HEK293 Cells; Hematopoietic Stem Cells; Hemodynamics; Hep G2 Cells; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Hepatocytes; Hesperidin; High-Frequency Ventilation; High-Temperature Requirement A Serine Peptidase 1; Hippocampus; Hirudins; History, 20th Century; History, 21st Century; HIV Infections; Homeostasis; Hominidae; Housing, Animal; Humans; Hydrocarbons, Brominated; Hydrogen Bonding; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxybutyrates; Hydroxyl Radical; Hypertension; Hypothyroidism; Image Interpretation, Computer-Assisted; Immunoconjugates; Immunogenic Cell Death; Indoles; Infant, Newborn; Infant, Premature; Infarction, Middle Cerebral Artery; Inflammation; Inflammation Mediators; Infrared Rays; Inhibitory Concentration 50; Injections, Intravenous; Interferon-gamma; Interleukin-23; Interleukin-4; Interleukin-6; Intermediate Filaments; Intermittent Claudication; Intestine, Small; Iridoid Glucosides; Iridoids; Iron; Isomerism; Isotope Labeling; Isoxazoles; Itraconazole; Kelch-Like ECH-Associated Protein 1; Ketoprofen; Kidney Failure, Chronic; Kinetics; Klebsiella pneumoniae; Lactams, Macrocyclic; Lactobacillus; Lactulose; Lakes; Lamivudine; Laparoscopy; Laparotomy; Laryngoscopy; Leucine; Limit of Detection; Linear Models; Lipid A; Lipopolysaccharides; Listeria monocytogenes; Liver; Liver Cirrhosis; Logistic Models; Longitudinal Studies; Losartan; Low Back Pain; Lung; Lupinus; Lupus Erythematosus, Systemic; Machine Learning; Macular Degeneration; Madin Darby Canine Kidney Cells; Magnetic Phenomena; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetics; Malaria, Falciparum; Male; Mannans; MAP Kinase Signaling System; Mass Spectrometry; Melatonin; Membrane Glycoproteins; Membrane Proteins; Meniscectomy; Menisci, Tibial; Mephenytoin; Mesenchymal Stem Cells; Metal Nanoparticles; Metal-Organic Frameworks; Methionine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Mice, Transgenic; Microbial Sensitivity Tests; Microcirculation; MicroRNAs; Microscopy, Video; Microtubules; Microvascular Density; Microwaves; Middle Aged; Minimally Invasive Surgical Procedures; Models, Animal; Models, Biological; Models, Molecular; Models, Theoretical; Molecular Docking Simulation; Molecular Structure; Molecular Weight; Morus; Mouth Floor; Multicenter Studies as Topic; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Muscle, Skeletal; Myocardial Ischemia; Myocardium; NAD; NADP; Nanocomposites; Nanoparticles; Naphthols; Nasal Lavage Fluid; Nasal Mucosa; Neisseria meningitidis; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neural Stem Cells; Neuroblastoma; Neurofilament Proteins; Neurogenesis; Neurons; New York; NF-E2-Related Factor 2; NF-kappa B; Nicotine; Nitriles; Nitrogen; Nitrogen Fixation; North America; Observer Variation; Occupational Exposure; Ochrobactrum; Oils, Volatile; Olea; Oligosaccharides; Omeprazole; Open Field Test; Optimism; Oregon; Oryzias; Osmolar Concentration; Osteoarthritis; Osteoblasts; Osteogenesis; Ovarian Neoplasms; Ovariectomy; Oxadiazoles; Oxidation-Reduction; Oxidative Stress; Oxygen; Ozone; p38 Mitogen-Activated Protein Kinases; Pakistan; Pandemics; Particle Size; Particulate Matter; Patient-Centered Care; Pelargonium; Peptides; Perception; Peripheral Arterial Disease; Peroxides; Pets; Pharmaceutical Preparations; Pharmacogenetics; Phenobarbital; Phenols; Phenotype; Phosphates; Phosphatidylethanolamines; Phosphines; Phospholipids; Phosphorus; Phosphorylation; Photoacoustic Techniques; Photochemotherapy; Photosensitizing Agents; Phylogeny; Phytoestrogens; Pilot Projects; Plant Components, Aerial; Plant Extracts; Plant Immunity; Plant Leaves; Plant Oils; Plants, Medicinal; Plasmodium berghei; Plasmodium falciparum; Platelet Activation; Platelet Function Tests; Pneumonia, Viral; Poaceae; Pogostemon; Poloxamer; Poly I; Poly(ADP-ribose) Polymerase Inhibitors; Polychlorinated Biphenyls; Polychlorinated Dibenzodioxins; Polycyclic Compounds; Polyethylene Glycols; Polylysine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Population Dynamics; Portasystemic Shunt, Transjugular Intrahepatic; Positron Emission Tomography Computed Tomography; Postoperative Complications; Postprandial Period; Potassium Cyanide; Predictive Value of Tests; Prefrontal Cortex; Pregnancy; Prepulse Inhibition; Prevalence; Procalcitonin; Prodrugs; Prognosis; Progression-Free Survival; Proline; Proof of Concept Study; Prospective Studies; Protein Binding; Protein Conformation; Protein Domains; Protein Folding; Protein Multimerization; Protein Sorting Signals; Protein Structure, Secondary; Proton Pump Inhibitors; Protozoan Proteins; Psychometrics; Pulse Wave Analysis; Pyridines; Pyrrolidines; Quality of Life; Quantum Dots; Quinoxalines; Quorum Sensing; Radiopharmaceuticals; Rain; Random Allocation; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Rats, Wistar; RAW 264.7 Cells; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, PAR-1; Receptors, CXCR4; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Interleukin-1; Receptors, Interleukin-17; Receptors, Notch; Recombinant Fusion Proteins; Recombinant Proteins; Reducing Agents; Reflex, Startle; Regional Blood Flow; Regression Analysis; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Tract Diseases; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Risk Assessment; Risk Factors; Rituximab; RNA, Messenger; RNA, Ribosomal, 16S; ROC Curve; Rosmarinic Acid; Running; Ruthenium; Rutin; Sarcolemma; Sarcoma; Sarcopenia; Sarcoplasmic Reticulum; SARS-CoV-2; Scavenger Receptors, Class A; Schools; Seasons; Seeds; Sequence Analysis, DNA; Severity of Illness Index; Sex Factors; Shock, Cardiogenic; Short Chain Dehydrogenase-Reductases; Signal Transduction; Silver; Singlet Oxygen; Sinusitis; Skin; Skin Absorption; Small Molecule Libraries; Smoke; Socioeconomic Factors; Soil; Soil Microbiology; Solid Phase Extraction; Solubility; Solvents; Spain; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Speech; Speech Perception; Spindle Poles; Spleen; Sporothrix; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Stomach Neoplasms; Stress, Physiological; Stroke Volume; Structure-Activity Relationship; Substrate Specificity; Sulfonamides; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Rate; T-Lymphocytes, Cytotoxic; Tandem Mass Spectrometry; Temperature; Tenofovir; Terpenes; Tetracycline; Tetrapleura; Textiles; Thermodynamics; Thiobarbituric Acid Reactive Substances; Thrombin; Thyroid Hormones; Thyroid Neoplasms; Tibial Meniscus Injuries; Time Factors; Tissue Distribution; Titanium; Toluidines; Tomography, X-Ray Computed; Tooth; Tramadol; Transcription Factor AP-1; Transcription, Genetic; Transfection; Transgender Persons; Translations; Treatment Outcome; Triglycerides; Ubiquinone; Ubiquitin-Specific Proteases; United Kingdom; United States; Up-Regulation; Vascular Stiffness; Veins; Ventricular Remodeling; Viral Load; Virulence Factors; Virus Replication; Vitis; Voice; Voice Quality; Wastewater; Water; Water Pollutants, Chemical; Water-Electrolyte Balance; Weather; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Young Adult; Zoogloea

2022
    American journal of obstetrics & gynecology MFM, 2021, Volume: 3, Issue:1

    Topics: Adipose Tissue, White; Adult; Aged; Air Pollutants; Animals; Anti-Inflammatory Agents; Arginine; bcl-2-Associated X Protein; Biofuels; Biological Products; Blood Glucose; Breast Neoplasms; Caspases; CD36 Antigens; Cell Communication; Cell Proliferation; Cell Survival; Cooking; Cross-Sectional Studies; Databases, Factual; Diabetes Mellitus, Type 2; Diphtheria Toxin; Double-Blind Method; Exenatide; Extracellular Polymeric Substance Matrix; Feasibility Studies; Female; Filgrastim; Fruit; Galactose; Gene Deletion; Gene Knockdown Techniques; Glucagon; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glycated Hemoglobin; Hematopoietic Stem Cell Mobilization; Household Articles; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Lung; Lymphoma; Male; Metals, Heavy; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Nanoparticles; Neoplasms; Obesity; Obstetrics; Odds Ratio; Oxygen; Peripheral Blood Stem Cell Transplantation; Photochemotherapy; Plant Extracts; Polyethylene Glycols; Polyglutamic Acid; Porosity; Postprandial Period; Prospective Studies; Quality of Life; Receptors, Glucagon; Receptors, LDL; Receptors, Somatostatin; Registries; Rhodophyta; Rhodotorula; Risk Factors; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Signal Transduction; Somatostatin; Stilbenes; Terminalia; Treatment Outcome; United States; Venoms

2021
FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:8

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Base Sequence; Breast Neoplasms; Chemotherapy, Adjuvant; DNA Primers; Female; Genotype; Humans; Immunohistochemistry; Middle Aged; Prognosis; Receptor, Fibroblast Growth Factor, Type 4; Remission Induction

2010
Natural cytotoxicity in breast cancer patients receiving neoadjuvant chemotherapy: effects of L-arginine supplementation.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 1994, Volume: 20, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Middle Aged; Prednisone; Vincristine

1994
Dietary supplementation with L-arginine in patients with breast cancer (> 4 cm) receiving multimodality treatment: report of a feasibility study.
    British journal of cancer, 1994, Volume: 69, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Feasibility Studies; Female; Humans; Mammography; Mastectomy; Middle Aged; Neoplasm Staging; Prednisone; Radiotherapy Dosage; Ultrasonography; Vincristine

1994
Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: results of a randomised controlled trial.
    International journal of oncology, 1998, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Cyclophosphamide; Dietary Supplements; Double-Blind Method; Doxorubicin; Drug Synergism; Female; Humans; Mastectomy; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Prednisone; Radiotherapy, Adjuvant; Vincristine

1998
Stimulation of human breast cancers by dietary L-arginine.
    Clinical science (London, England : 1979), 1992, Volume: 82, Issue:4

    Topics: Administration, Oral; Arginine; Breast Neoplasms; Female; Humans; Ki-67 Antigen; Mitosis; Neoplasm Proteins; Nuclear Proteins; Stimulation, Chemical

1992
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
    Bulletin du cancer, 1984, Volume: 71, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine

1984
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1977, Issue:62

    Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide

1977
Teniposide in advanced breast cancer. A phase II trial in patients with no prior chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Middle Aged; Teniposide

1992

Other Studies

157 other study(ies) available for arginine and Breast Cancer

ArticleYear
Ultrasound and magnetic resonance imaging of cyclic arginine glycine aspartic acid-gadopentetic acid-polylactic acid in human breast cancer by targeting αvβ3 in xenograft-bearing nude mice.
    Bioengineered, 2022, Volume: 13, Issue:3

    Topics: Animals; Arginine; Aspartic Acid; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Glycine; Heterografts; Humans; Magnetic Resonance Imaging; Mice; Mice, Nude; Polyesters

2022
An integrated metabonomics study to reveal the inhibitory effect and metabolism regulation of taurine on breast cancer.
    Journal of pharmaceutical and biomedical analysis, 2022, May-30, Volume: 214

    Topics: Animals; Arginine; Breast Neoplasms; Choline; Female; Glutamic Acid; Histidine; Humans; Isoleucine; Lactic Acid; Leucine; Lung Neoplasms; Metabolomics; Mice; Taurine; Valine

2022
Combination of Electrochemistry and Mass Spectrometry to Study Nitric Oxide Metabolism and Its Modulation by Compound K in Breast Cancer Cells.
    Analytical chemistry, 2022, 03-29, Volume: 94, Issue:12

    Topics: Arginine; Breast Neoplasms; Electrochemistry; Female; Ginsenosides; Humans; Metal Nanoparticles; Nitric Oxide; Pharmaceutical Preparations; Platinum; Tandem Mass Spectrometry

2022
Investigation of the Lethal Effect of Purified Arginine Deiminase Purified from Lactobacillus plantarum p5 on Murine Mammary Adenocarcinoma and Vero cell Lines.
    Archives of Razi Institute, 2022, Volume: 77, Issue:1

    Topics: Adenocarcinoma; Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Chlorocebus aethiops; Hydrolases; Lactobacillus plantarum; Mammary Neoplasms, Animal; Mice; Vero Cells

2022
LAP3 contributes to IFN-γ-induced arginine depletion and malignant transformation of bovine mammary epithelial cells.
    BMC cancer, 2022, Aug-08, Volume: 22, Issue:1

    Topics: Animals; Arginine; Argininosuccinate Synthase; Breast; Breast Neoplasms; Cattle; Cell Transformation, Neoplastic; Epithelial Cells; Female; Humans; Interferon-gamma; Leucyl Aminopeptidase

2022
L-arginase from Streptomyces diastaticus MAM5 as a potential therapeutic agent in breast cancer: Purification, characterization, G1 phase arrest and autophagy induction.
    International journal of biological macromolecules, 2023, Jan-01, Volume: 224

    Topics: Apoptosis; Arginase; Arginine; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; G1 Phase; Humans

2023
Anti-cancer effect of Rumex obtusifolius in combination with arginase/nitric oxide synthase inhibitors via downregulation of oxidative stress, inflammation, and polyamine synthesis.
    The international journal of biochemistry & cell biology, 2023, Volume: 158

    Topics: Animals; Antioxidants; Arginase; Arginine; Breast Neoplasms; Down-Regulation; Female; Humans; Inflammation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Polyamines; Rats; Rumex

2023
Proteome-wide Profiling of Asymmetric Dimethylated Arginine in Human Breast Tumors.
    Journal of the American Society for Mass Spectrometry, 2023, Aug-02, Volume: 34, Issue:8

    Topics: Arginine; Breast Neoplasms; Chromatography, Liquid; Female; Humans; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Proteome; Repressor Proteins; Tandem Mass Spectrometry

2023
Common alterations in plasma free amino acid profiles and gut microbiota-derived tryptophan metabolites of five types of cancer patients.
    Amino acids, 2023, Volume: 55, Issue:9

    Topics: Amino Acids; Arginine; Breast Neoplasms; Female; Gastrointestinal Microbiome; Humans; Tryptophan; Tumor Microenvironment

2023
PRMT6 methylation of STAT3 regulates tumor metastasis in breast cancer.
    Cell death & disease, 2023, 10-09, Volume: 14, Issue:10

    Topics: Arginine; Breast Neoplasms; Female; Humans; Methylation; Nuclear Proteins; Protein-Arginine N-Methyltransferases; STAT3 Transcription Factor

2023
    Scientific reports, 2019, 09-10, Volume: 9, Issue:1

    Topics: Animals; Apoptosis; Arginine; Breast Neoplasms; Cell Proliferation; Female; Fluorodeoxyglucose F18; Humans; Mice; Mice, Nude; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Neuropeptide Y; Tissue Distribution; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2019
The potential therapeutic effect of N
    Experimental and molecular pathology, 2019, Volume: 111

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Arginase; Arginine; Breast Neoplasms; Female; Mortality; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Polyamines; Rats, Wistar

2019
A Supramolecular Stabilizer of the 14-3-3ζ/ERα Protein-Protein Interaction with a Synergistic Mode of Action.
    Angewandte Chemie (International ed. in English), 2020, 03-23, Volume: 59, Issue:13

    Topics: 14-3-3 Proteins; Amino Acid Motifs; Amino Acid Sequence; Arginine; Breast Neoplasms; Estrogen Receptor alpha; Glycosides; Humans; Molecular Dynamics Simulation; Peptides; Protein Binding

2020
The effect of opine on matrix metalloproteinase expression in mice with breast cancer.
    Archives of physiology and biochemistry, 2022, Volume: 128, Issue:2

    Topics: Animals; Arginine; Breast Neoplasms; Female; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Matrix Metalloproteinase 9; Matrix Metalloproteinases, Secreted; Mice; Mice, Inbred BALB C

2022
Arginine methylation-dependent LSD1 stability promotes invasion and metastasis of breast cancer.
    EMBO reports, 2020, 02-05, Volume: 21, Issue:2

    Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Histone Demethylases; Humans; Methylation; Protein Processing, Post-Translational; Ubiquitin-Specific Peptidase 7

2020
C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.
    Journal of experimental & clinical cancer research : CR, 2020, Jan-13, Volume: 39, Issue:1

    Topics: Animals; Arginine; Benzhydryl Compounds; Breast Neoplasms; Cancer-Associated Fibroblasts; Cell Line, Tumor; Complement C3; Cytokines; Extracellular Matrix Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Transplantation; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptors, Complement; Signal Transduction

2020
PRMT6-mediated H3R2me2a guides Aurora B to chromosome arms for proper chromosome segregation.
    Nature communications, 2020, 01-30, Volume: 11, Issue:1

    Topics: Amino Acid Sequence; Arginine; Aurora Kinase B; Breast Neoplasms; Centromere; Chromosomal Proteins, Non-Histone; Chromosome Segregation; Chromosomes, Human; Cytokinesis; Demethylation; Disease Progression; Female; HeLa Cells; Histones; Humans; MCF-7 Cells; Methylation; Mitosis; Nuclear Proteins; Phosphorylation; Protein-Arginine N-Methyltransferases; RNA, Small Interfering

2020
Correction of arginine metabolism with sepiapterin-the precursor of nitric oxide synthase cofactor BH
    Biochemical pharmacology, 2020, Volume: 176

    Topics: Arginine; B7-H1 Antigen; Biopterins; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Humans; Macrophages; Nitric Oxide; Nitric Oxide Synthase; Polyamines; Pterins; STAT3 Transcription Factor; THP-1 Cells

2020
Protein arginine deiminase 4 antagonizes methylglyoxal-induced histone glycation.
    Nature communications, 2020, 06-26, Volume: 11, Issue:1

    Topics: Animals; Arginine; Breast Neoplasms; Citrullination; Citrulline; Female; Glycosylation; Histones; Humans; MCF-7 Cells; Methylation; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Nucleosomes; Protein-Arginine Deiminase Type 4; Pyruvaldehyde

2020
Arginine methylation of SHANK2 by PRMT7 promotes human breast cancer metastasis through activating endosomal FAK signalling.
    eLife, 2020, 08-26, Volume: 9

    Topics: Animals; Arginine; Breast; Breast Neoplasms; Cell Line, Tumor; Endosomes; Female; Focal Adhesion Kinase 1; Humans; Methylation; Mice; Mice, Inbred BALB C; Nerve Tissue Proteins; Protein-Arginine N-Methyltransferases

2020
Pharmacologic downregulation of protein arginine methyltransferase1 expression by adenosine dialdehyde increases cell senescence in breast cancer.
    European journal of pharmacology, 2021, Jan-15, Volume: 891

    Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Arginine; Betaine-Homocysteine S-Methyltransferase; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Cellular Senescence; Down-Regulation; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Methylation; Molecular Docking Simulation; Oxidative Stress; Phosphatidylethanolamine N-Methyltransferase; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Repressor Proteins; Signal Transduction; Tamoxifen

2021
Gene-Environment Interaction between Arg72Pro SNP and Selected Environmental Exposures among Brazilian Women Diagnosed with Benign Breast Disease.
    Asian Pacific journal of cancer prevention : APJCP, 2020, Dec-01, Volume: 21, Issue:12

    Topics: Arginine; Brazil; Breast Neoplasms; Cross-Sectional Studies; Environmental Exposure; Female; Follow-Up Studies; Gene-Environment Interaction; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Tumor Suppressor Protein p53

2020
Indicators of L-arginine metabolism in saliva: A focus on breast cancer.
    Journal of oral biosciences, 2021, Volume: 63, Issue:1

    Topics: Arginase; Arginine; Breast Neoplasms; Case-Control Studies; Humans; Saliva

2021
RNF167 activates mTORC1 and promotes tumorigenesis by targeting CASTOR1 for ubiquitination and degradation.
    Nature communications, 2021, 02-16, Volume: 12, Issue:1

    Topics: Animals; Arginine; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Disease Progression; Female; Intercellular Signaling Peptides and Proteins; Intracellular Signaling Peptides and Proteins; Kinetics; Lysine; Mechanistic Target of Rapamycin Complex 1; Mice, Nude; Phosphorylation; Proteolysis; Proto-Oncogene Proteins c-akt; Ubiquitin-Protein Ligases; Ubiquitination

2021
Profiling PRMT methylome reveals roles of hnRNPA1 arginine methylation in RNA splicing and cell growth.
    Nature communications, 2021, 03-29, Volume: 12, Issue:1

    Topics: Alternative Splicing; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HEK293 Cells; Heterogeneous Nuclear Ribonucleoprotein A1; Humans; Male; Methylation; Prostatic Neoplasms; Protein Binding; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; RNA, Small Interfering; Spliceosomes; Substrate Specificity

2021
Arginine and lysine methylation of MRPS23 promotes breast cancer metastasis through regulating OXPHOS.
    Oncogene, 2021, Volume: 40, Issue:20

    Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Lysine; Methylation; Mitochondria; Neoplasm Metastasis; Organoids; Oxidative Phosphorylation; Protein Methyltransferases; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases

2021
The comparison of Zn(II) arginine dithiocarbamate cytotoxicity in T47D breast cancer and fibroblast cells.
    Breast disease, 2021, Volume: 40, Issue:S1

    Topics: Antineoplastic Agents; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Congresses as Topic; Female; Fibroblasts; Humans; Thiocarbamates; Zinc

2021
PRMT5-mediated arginine methylation activates AKT kinase to govern tumorigenesis.
    Nature communications, 2021, 06-08, Volume: 12, Issue:1

    Topics: Animals; Antineoplastic Agents; Arginine; Biocatalysis; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Membrane; Cell Proliferation; Enzyme Activation; Female; HEK293 Cells; Humans; Methylation; Mice, Nude; Mutation; Protein Binding; Protein Kinase Inhibitors; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Small Interfering; Signal Transduction

2021
siRNA-loaded poly(histidine-arginine)
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell-Penetrating Peptides; Chitosan; Endosomes; Female; Histidine; Humans; Mice, Inbred BALB C; Nanoparticles; RNA, Small Interfering; Transfection; Xenograft Model Antitumor Assays

2017
Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition.
    Nature communications, 2017, 05-24, Volume: 8

    Topics: Amino Acid Motifs; Antineoplastic Agents; Arginine; Breast Neoplasms; Chromatography, High Pressure Liquid; Computational Biology; Enzyme Inhibitors; Female; Gene Knockout Techniques; HEK293 Cells; Humans; MCF-7 Cells; Methylation; Molecular Targeted Therapy; Mutation; Proline; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Substrate Specificity; Tandem Mass Spectrometry

2017
The Horizon in Cardio-Oncology: "You Are Only as Good as Your Endothelium".
    Journal of the American College of Cardiology, 2017, 07-11, Volume: 70, Issue:2

    Topics: Arginine; Breast Neoplasms; Endothelium; Heart Diseases; Humans; Neoplasms; Nitric Oxide

2017
Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer.
    Journal of the American College of Cardiology, 2017, Jul-11, Volume: 70, Issue:2

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Arginine; Biomarkers, Tumor; Breast Neoplasms; Cardiomyopathies; Doxorubicin; Female; Follow-Up Studies; Humans; Middle Aged; Nitric Oxide; Oxidative Stress; Prospective Studies; Time Factors; Trastuzumab

2017
Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.
    Clinical nutrition (Edinburgh, Scotland), 2018, Volume: 37, Issue:5

    Topics: Adult; Arginine; Breast Neoplasms; Citrulline; Female; Genetic Predisposition to Disease; Glutamine; Humans; Mastectomy; Metabolic Clearance Rate; Middle Aged; Nitric Oxide; Postoperative Complications; Postprandial Period

2018
Cancer-associated arginine-to-histidine mutations confer a gain in pH sensing to mutant proteins.
    Science signaling, 2017, Sep-05, Volume: 10, Issue:495

    Topics: Arginine; Breast Neoplasms; Carcinogenesis; Cell Proliferation; ErbB Receptors; Female; Histidine; Humans; Hydrogen-Ion Concentration; Mutation; Protein Conformation; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2017
Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction.
    Journal of the American College of Cardiology, 2017, 12-19, Volume: 70, Issue:24

    Topics: Arginine; Breast Neoplasms; Heart Diseases; Humans; Nitric Oxide

2017
Flow-Mediated Dilation of Brachial Artery as a Screening Tool for Anthracycline-Induced Cardiotoxicity.
    Journal of the American College of Cardiology, 2017, 12-19, Volume: 70, Issue:24

    Topics: Anthracyclines; Arginine; Brachial Artery; Breast Neoplasms; Cardiotoxicity; Dilatation; Early Detection of Cancer; Heart Diseases; Humans; Nitric Oxide

2017
Reply: Statistical Analyses of Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction.
    Journal of the American College of Cardiology, 2017, 12-19, Volume: 70, Issue:24

    Topics: Arginine; Breast Neoplasms; Heart Diseases; Humans; Nitric Oxide

2017
A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.
    Neoplasia (New York, N.Y.), 2018, Volume: 20, Issue:2

    Topics: Animals; Apoptosis; Arginine; Binding Sites; Breast Neoplasms; Cell Movement; Cell Proliferation; Chitinase-3-Like Protein 1; Female; Heparin; Humans; Lysine; Mice; Mice, SCID; Mutation; Neovascularization, Pathologic; Protein Binding; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2018
Arginine inhibits the malignant transformation induced by interferon-gamma through the NF-κB-GCN2/eIF2α signaling pathway in mammary epithelial cells in vitro and in vivo.
    Experimental cell research, 2018, 07-15, Volume: 368, Issue:2

    Topics: Animals; Arginine; Breast; Breast Neoplasms; Cattle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Epithelial Cells; Eukaryotic Initiation Factor-2; Female; Humans; Interferon-gamma; Mice; NF-kappa B; Protein Serine-Threonine Kinases; Protein Transport; Signal Transduction

2018
Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells.
    Amino acids, 2018, Volume: 50, Issue:11

    Topics: Arginine; Breast Neoplasms; Cell Line, Tumor; Estrogens; Female; Humans; MCF-7 Cells; Receptors, Estrogen

2018
L-arginine/5-fluorouracil combination treatment approaches cells selectively: Rescuing endothelial cells while killing MDA-MB-468 breast cancer cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2019, Volume: 123

    Topics: Antineoplastic Agents; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Fluorouracil; Glycolysis; Human Umbilical Vein Endothelial Cells; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Docking Simulation; Nitric Oxide; Vascular Endothelial Growth Factor A

2019
Arginine Citrullination at the C-Terminal Domain Controls RNA Polymerase II Transcription.
    Molecular cell, 2019, 01-03, Volume: 73, Issue:1

    Topics: Arginine; Breast Neoplasms; Cell Proliferation; Citrullination; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; MCF-7 Cells; Positive Transcriptional Elongation Factor B; Promoter Regions, Genetic; Protein Binding; Protein Domains; Protein Processing, Post-Translational; Protein-Arginine Deiminase Type 2; Protein-Arginine Deiminases; RNA Polymerase II; Signal Transduction; Transcription, Genetic

2019
Alterations in arginine and energy metabolism, structural and signalling lipids in metastatic breast cancer in mice detected in plasma by targeted metabolomics and lipidomics.
    Breast cancer research : BCR, 2018, 12-04, Volume: 20, Issue:1

    Topics: Animals; Arginase; Arginine; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Models, Animal; Energy Metabolism; Female; Humans; Lipid Metabolism; Lipids; Metabolomics; Mice; Mice, Inbred BALB C; Neoplasm Staging; Polyamines; Tandem Mass Spectrometry

2018
Effectiveness of Small Interfering RNA Delivery via Arginine-Rich Polyethylenimine-Based Polyplex in Metastatic and Doxorubicin-Resistant Breast Cancer Cells.
    The Journal of pharmacology and experimental therapeutics, 2019, Volume: 370, Issue:3

    Topics: Antibiotics, Antineoplastic; Arginine; ATP Binding Cassette Transporter, Subfamily B; Breast Neoplasms; Cell Line, Tumor; Doxorubicin; Drug Compounding; Drug Delivery Systems; Drug Resistance, Neoplasm; Female; Gene Knockdown Techniques; Humans; MCF-7 Cells; Molecular Structure; Polyethyleneimine; RNA, Small Interfering

2019
Methylation of C/EBPα by PRMT1 Inhibits Its Tumor-Suppressive Function in Breast Cancer.
    Cancer research, 2019, 06-01, Volume: 79, Issue:11

    Topics: Animals; Arginine; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Histone Deacetylases; Humans; Methylation; Mice, Inbred BALB C; Protein-Arginine N-Methyltransferases; Repressor Proteins; Xenograft Model Antitumor Assays

2019
PELP1 oncogenic functions involve CARM1 regulation.
    Carcinogenesis, 2013, Volume: 34, Issue:7

    Topics: Animals; Arginine; Breast Neoplasms; Chromatin Immunoprecipitation; Co-Repressor Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; MCF-7 Cells; Methylation; Mice; Promoter Regions, Genetic; Protein Interaction Mapping; Protein-Arginine N-Methyltransferases; Proto-Oncogene Mas; Proto-Oncogene Proteins; RNA, Small Interfering; Transcription Factors; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2013
High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics.
    ACS nano, 2013, Nov-26, Volume: 7, Issue:11

    Topics: Animals; Arginine; Breast Neoplasms; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Profiling; Gene Silencing; Heat-Shock Proteins; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; MicroRNAs; Microscopy, Electron, Scanning; Nanomedicine; Nanoparticles; Polyethyleneimine; RNA, Small Interfering; Silicon; STAT3 Transcription Factor

2013
Proteomic identification of mitochondrial targets of arginase in human breast cancer.
    PloS one, 2013, Volume: 8, Issue:11

    Topics: Animals; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Electrophoresis, Gel, Two-Dimensional; Female; Glycine Hydroxymethyltransferase; Humans; Mass Spectrometry; Mice; Mice, Nude; Middle Aged; Mitochondria; Mitochondrial Proteins; Proteomics; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Transplantation, Heterologous; Tumor Burden

2013
JMJD6 regulates ERα methylation on arginine.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Arginine; Blotting, Western; Breast Neoplasms; Chromatography, Affinity; DNA Methylation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; Image Processing, Computer-Assisted; Immunoprecipitation; Jumonji Domain-Containing Histone Demethylases; Protein Processing, Post-Translational; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured

2014
Arginine starvation impairs mitochondrial respiratory function in ASS1-deficient breast cancer cells.
    Science signaling, 2014, Apr-01, Volume: 7, Issue:319

    Topics: Adult; Aged; Aged, 80 and over; Animals; Apoptosis; Arginine; Argininosuccinate Synthase; Autophagy; Breast Neoplasms; Cell Line, Tumor; Disease-Free Survival; Female; Humans; Hydrolases; Interleukin Receptor Common gamma Subunit; MCF-7 Cells; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Microscopy, Electron, Transmission; Middle Aged; Mitochondria; Polyethylene Glycols; Prognosis; Xenograft Model Antitumor Assays

2014
Protein arginine methyltransferase 6 enhances ligand-dependent and -independent activity of estrogen receptor α via distinct mechanisms.
    Biochimica et biophysica acta, 2014, Volume: 1843, Issue:9

    Topics: Amino Acid Motifs; Amino Acid Sequence; Arginine; Binding, Competitive; Breast Neoplasms; Cell Nucleus; Cell Proliferation; Estrogen Receptor alpha; Female; Gene Silencing; HSP90 Heat-Shock Proteins; Humans; Ligands; MCF-7 Cells; Methylation; Molecular Sequence Data; Nuclear Proteins; Protein Binding; Protein-Arginine N-Methyltransferases; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; src-Family Kinases; Up-Regulation

2014
The therapy of gefitinib towards breast cancer partially through reversing breast cancer biomarker arginine.
    African health sciences, 2015, Volume: 15, Issue:2

    Topics: Adult; Antineoplastic Agents; Area Under Curve; Arginine; Breast Neoplasms; Case-Control Studies; Female; Gefitinib; Humans; Mass Spectrometry; Metabolomics; Predictive Value of Tests; Quinazolines; ROC Curve; Sensitivity and Specificity

2015
Argininosuccinate lyase is a potential therapeutic target in breast cancer.
    Oncology reports, 2015, Volume: 34, Issue:6

    Topics: Arginine; Argininosuccinate Lyase; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin A2; Endoplasmic Reticulum Stress; Female; Gene Expression Regulation, Neoplastic; Humans; Nitric Oxide; RNA, Small Interfering

2015
Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis.
    Nature communications, 2015, Sep-30, Volume: 6

    Topics: Amino Acid Motifs; Arginine; Breast Neoplasms; Carcinogenesis; Cell Line, Tumor; DNA Damage; Female; Gene Expression Regulation, Neoplastic; Genomic Instability; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Methylation; Protein-Arginine N-Methyltransferases; Ubiquitination

2015
Free DOX and chitosan-N-arginine conjugate stabilized indocyanine green nanoparticles for combined chemophotothermal therapy.
    Colloids and surfaces. B, Biointerfaces, 2015, Dec-01, Volume: 136

    Topics: Antibiotics, Antineoplastic; Arginine; Breast Neoplasms; Chitosan; Combined Modality Therapy; Doxorubicin; Humans; Hyperthermia, Induced; Indocyanine Green; MCF-7 Cells; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Nanoparticles; Phototherapy

2015
[Association of the Arg399Gln polymorphisms of the XRCC1 gene with breast cancer risk in Kyrgiz women].
    Voprosy onkologii, 2015, Volume: 61, Issue:6

    Topics: Adult; Aged; Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; DNA, Neoplasm; Female; Genetic Predisposition to Disease; Genotype; Glutamine; Heterozygote; Humans; Kyrgyzstan; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Assessment; Risk Factors; X-ray Repair Cross Complementing Protein 1

2015
An asymmetrically dimethylarginated nuclear 90 kDa protein (p90aDMA) induced by interleukin (IL)-2, IL-4 or IL-6 in the tumor microenvironment is selectively degraded by autophagy.
    International journal of oncology, 2016, Volume: 48, Issue:6

    Topics: Arginine; Autophagy; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Interleukin-2; Interleukin-4; Interleukin-6; MCF-7 Cells; Molecular Weight; Nuclear Proteins; Protein Processing, Post-Translational; Sirolimus; Tumor Microenvironment; Uterine Cervical Neoplasms

2016
A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Oncogene, 2017, 01-19, Volume: 36, Issue:3

    Topics: A549 Cells; Adaptor Proteins, Signal Transducing; Adenocarcinoma; Adenocarcinoma of Lung; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Lung Neoplasms; MCF-7 Cells; Methylation; Neoplasm Invasiveness; Neoplasms; Prognosis; Protein-Arginine N-Methyltransferases; Sequence Analysis, RNA; Transcription, Genetic; Transforming Growth Factor beta

2017
N
    Amino acids, 2016, Volume: 48, Issue:11

    Topics: Arginine; Biomarkers, Tumor; Breast Neoplasms; Female; Humans; MCF-7 Cells; Receptors, Estrogen

2016
A nanobiosensor for the detection of arginase activity.
    Nanomedicine : nanotechnology, biology, and medicine, 2017, Volume: 13, Issue:2

    Topics: Animals; Arginase; Arginine; Biosensing Techniques; Breast Neoplasms; Metal Nanoparticles; Mice, Inbred BALB C; Nitric Oxide; Ornithine

2017
Identification of arginine and its "Downstream" molecules as potential markers of breast cancer.
    IUBMB life, 2016, Volume: 68, Issue:10

    Topics: Adolescent; Adult; Aged; Arginine; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; Female; Humans; Middle Aged; Ornithine; ROC Curve; Spermine; Young Adult

2016
Association of plasma arginine with breast cancer molecular subtypes in women of Liaoning province.
    IUBMB life, 2016, Volume: 68, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Arginine; Biomarkers, Tumor; Breast Neoplasms; Case-Control Studies; China; Female; Humans; Middle Aged; ROC Curve

2016
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 88

    Topics: Apoptosis; Arginine; Breast Neoplasms; Cell Movement; Cell Survival; Chemokine CXCL12; Female; Fluorouracil; Gene Expression Regulation, Neoplastic; Glucosephosphate Dehydrogenase; Humans; Lactic Acid; MCF-7 Cells; Models, Biological; Neoplasm Invasiveness; Nitric Oxide; Receptors, CXCR4; RNA, Messenger

2017
Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.
    Endocrinology, 2008, Volume: 149, Issue:10

    Topics: 3-Mercaptopropionic Acid; Apoptosis; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dipeptides; Estradiol; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Nitric Oxide; Prolactin; Protease Inhibitors; Proteins; RNA, Messenger; Transfection; Up-Regulation

2008
Role of p53 codon 72 arginine allele in cell survival in vitro and in the clinical outcome of patients with advanced breast cancer.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2008, Volume: 29, Issue:3

    Topics: Adult; Aged; Alleles; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Codon; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hypoxia; Kaplan-Meier Estimate; Middle Aged; Neoplasm Proteins; Polymorphism, Single Nucleotide; Proline; Transfection; Tumor Suppressor Protein p53; Up-Regulation

2008
Regulation of estrogen rapid signaling through arginine methylation by PRMT1.
    Molecular cell, 2008, Jul-25, Volume: 31, Issue:2

    Topics: Animals; Arginine; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytoplasm; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogens; Genome, Human; Humans; Methylation; Mice; Models, Biological; NIH 3T3 Cells; Phosphatidylinositol 3-Kinases; Protein-Arginine N-Methyltransferases; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins pp60(c-src); Receptor Cross-Talk; Repressor Proteins; Signal Transduction; Substrate Specificity

2008
Structural basis for the selective inhibition of human 3beta-hydroxysteroid dehydrogenase 1 in human breast tumor MCF-7 cells.
    Molecular and cellular endocrinology, 2009, Mar-25, Volume: 301, Issue:1-2

    Topics: 3-Hydroxysteroid Dehydrogenases; Arginine; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Coenzymes; Dehydroepiandrosterone; Dihydrotestosterone; Enzyme Inhibitors; Estradiol; Estrone; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Mutant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substrate Specificity

2009
Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study.
    BMC cancer, 2008, Nov-18, Volume: 8

    Topics: Arginine; Breast Neoplasms; Carcinoma, Ductal, Breast; Case-Control Studies; Female; Gene Frequency; Genetic Predisposition to Disease; Glutamine; Humans; Nigeria; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; Postmenopause; Premenopause; Receptors, Leptin; Risk Factors; Signal Transduction

2008
Influence of protoporphyrin IX amino acid substituents on affinity to human breast adenocarcinoma MCF-7 cells.
    Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2009, Volume: 84, Issue:1

    Topics: Amino Acids, Diamino; Arginine; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Female; Histocytochemistry; Humans; Microscopy, Fluorescence; Protoporphyrins

2009
Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin.
    Familial cancer, 2009, Volume: 8, Issue:3

    Topics: Alternative Splicing; Amino Acid Substitution; Arginine; BRCA1 Protein; Breast Neoplasms; DNA Mutational Analysis; Genotype; Glycine; Haplotypes; Humans; Polymorphism, Single Nucleotide; Portugal; Reverse Transcriptase Polymerase Chain Reaction

2009
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study.
    Journal of hypertension, 2009, Volume: 27, Issue:3

    Topics: Adenocarcinoma; Adrenergic beta-Antagonists; Antihypertensive Agents; Arginine; Benzopyrans; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Size; Dose-Response Relationship, Drug; Drug Combinations; Elasticity; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogen Receptor beta; Estrogen Receptor Modulators; Estrogens; Ethanolamines; Female; Fulvestrant; Genes, Reporter; Humans; Metoprolol; Nanotechnology; Nebivolol; Nitric Oxide; Nitrites; Tamoxifen; Time Factors; Transfection

2009
The polymorphism of DNA repair gene ERCC2/XPD Arg156Arg and susceptibility to breast cancer in a Chinese population.
    Biochemical genetics, 2009, Volume: 47, Issue:7-8

    Topics: Adult; Age of Onset; Alleles; Arginine; Asian People; Breast Neoplasms; Case-Control Studies; DNA Repair; Female; Genetic Markers; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Polymorphism, Genetic; Xeroderma Pigmentosum Group D Protein

2009
Expression of the K303R estrogen receptor-alpha breast cancer mutation induces resistance to an aromatase inhibitor via addiction to the PI3K/Akt kinase pathway.
    Cancer research, 2009, Jun-01, Volume: 69, Issue:11

    Topics: Amino Acid Substitution; Animals; Arginine; Aromatase Inhibitors; Breast Neoplasms; CHO Cells; Cricetinae; Cricetulus; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Lysine; Mice; Mice, Nude; Mutation, Missense; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Prognosis; Signal Transduction; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2009
DN-R175H p53 mutation is more effective than p53 interference in inducing epithelial disorganization and activation of proliferation signals in human carcinoma cells: role of E-cadherin.
    International journal of cancer, 2009, Oct-01, Volume: 125, Issue:7

    Topics: Arginine; Breast Neoplasms; Cadherins; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cyclin A; Down-Regulation; Epithelial Cells; ErbB Receptors; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, Dominant; Genes, erbB-1; Histidine; Humans; Immunoblotting; Laser Scanning Cytometry; Matrix Metalloproteinase 9; Mutation; Phosphorylation; Retroviridae; RNA, Small Interfering; Transcriptional Activation; Transduction, Genetic; Tumor Suppressor Protein p53

2009
TP53 mutations and Arg72Pro polymorphism in breast cancers.
    Cancer genetics and cytogenetics, 2009, Jul-15, Volume: 192, Issue:2

    Topics: Amino Acid Substitution; Arginine; Breast Neoplasms; Case-Control Studies; Codon; Genotype; Humans; Lymphatic Metastasis; Mutation; Polymorphism, Single Nucleotide; Proline; Tumor Suppressor Protein p53

2009
TP53 codon 72 polymorphism and breast cancer in northern Iran.
    Oncology research, 2009, Volume: 18, Issue:1

    Topics: Adult; Arginine; Breast Neoplasms; Codon; Female; Gene Frequency; Genes, p53; Genotype; Heterozygote; Homozygote; Humans; Iran; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Proline; Risk Factors

2009
The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.
    Cell cycle (Georgetown, Tex.), 2010, Sep-01, Volume: 9, Issue:17

    Topics: 3-Hydroxybutyric Acid; Animals; Arginine; Autophagy; Biomarkers; Breast Neoplasms; Caveolin 1; Female; Gene Expression Profiling; Humans; Mice; MicroRNAs; Models, Biological; Oxidative Stress; Stromal Cells

2010
CAT-1-mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines.
    Journal of cellular biochemistry, 2011, Volume: 112, Issue:4

    Topics: Apoptosis; Arginine; Biological Transport; Blotting, Western; Breast Neoplasms; Cationic Amino Acid Transporter 1; Cationic Amino Acid Transporter 2; Cell Line, Tumor; Cell Nucleus; Cell Survival; Cytoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Microscopy, Confocal; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Prolactin; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference

2011
A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
    Biochemical and biophysical research communications, 2011, Apr-08, Volume: 407, Issue:2

    Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Arginine; Breast Neoplasms; Cell Line, Tumor; ErbB Receptors; Female; Histidine; Humans; Mice; Mice, Nude; Mutation; Peptides; Recombinant Fusion Proteins; Xenograft Model Antitumor Assays

2011
Cells derived from normal or cancer breast tissue exhibit different growth properties when deprived of arginine.
    Medical oncology (Northwood, London, England), 2012, Volume: 29, Issue:4

    Topics: Arginine; Breast; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Eflornithine; Female; Humans

2012
Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
    Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:8

    Topics: Alleles; Arginine; Breast Neoplasms; Case-Control Studies; Codon; Disease Progression; Female; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homozygote; Humans; India; Introns; Middle Aged; Neoplasm Staging; Obesity; Polymorphism, Genetic; Tumor Suppressor Protein p53

2011
The thrombin inhibitor, argatroban, inhibits breast cancer metastasis to bone.
    Breast cancer (Tokyo, Japan), 2013, Volume: 20, Issue:3

    Topics: Animals; Antithrombins; Arginine; Body Weight; Bone Neoplasms; Breast Neoplasms; Enzyme-Linked Immunosorbent Assay; Female; Humans; Mice; Pipecolic Acids; Sulfonamides; Thrombin; Thromboplastin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A

2013
Paclitaxel-conjugated PEG and arginine-grafted bioreducible poly (disulfide amine) micelles for co-delivery of drug and gene.
    Biomaterials, 2012, Volume: 33, Issue:32

    Topics: Animals; Antineoplastic Agents, Phytogenic; Arginine; Breast Neoplasms; Cell Line, Tumor; DNA; Female; Glutathione; Humans; Interleukin-12; Mice; Micelles; Paclitaxel; Particle Size; Polyamines; Polyethylene Glycols; Transfection

2012
The neuropeptide y y(1) receptor: a diagnostic marker? Expression in mcf-7 breast cancer cells is down-regulated by antiestrogens in vitro and in xenografts.
    PloS one, 2012, Volume: 7, Issue:12

    Topics: Animals; Arginine; Breast Neoplasms; Calcium; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Estradiol; Estrogen Receptor Modulators; Female; Fulvestrant; Humans; Mice; Mice, Nude; Neuropeptide Y; Receptors, Estrogen; Receptors, Neuropeptide Y; Tamoxifen

2012
Caspase-8-mediated BID cleavage and release of mitochondrial cytochrome c during Nomega-hydroxy-L-arginine-induced apoptosis in MDA-MB-468 cells. Antagonistic effects of L-ornithine.
    The Journal of biological chemistry, 2002, Oct-04, Volume: 277, Issue:40

    Topics: Apoptosis; Arginine; BH3 Interacting Domain Death Agonist Protein; Breast Neoplasms; Carrier Proteins; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; Female; Humans; Intracellular Membranes; Kinetics; Membrane Potentials; Mitochondria; Tumor Cells, Cultured

2002
The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas.
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2002, Volume: 11, Issue:12

    Topics: Alleles; Arginine; Base Sequence; Biopsy, Needle; Breast Neoplasms; Codon; Cohort Studies; Colorectal Neoplasms; DNA Mutational Analysis; Female; Genes, p53; Humans; Incidence; Loss of Heterozygosity; Male; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Probability; Prospective Studies; Risk Factors; Sensitivity and Specificity

2002
Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Oct-15, Volume: 9, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Alleles; Arginine; Breast Neoplasms; Cell Line, Tumor; Codon; Disease-Free Survival; DNA; Female; Genes, p53; Genotype; Heterozygote; Humans; Immunohistochemistry; Lymphatic Metastasis; Middle Aged; Nucleic Acid Hybridization; Polymorphism, Genetic; Prognosis; Proline; Time Factors

2003
Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
    Breast cancer (Tokyo, Japan), 2003, Volume: 10, Issue:4

    Topics: Adenine; Adult; Aged; Arginine; Breast Neoplasms; Carcinoma, Ductal; Case-Control Studies; Codon; Cytosine; DNA Primers; DNA-Binding Proteins; Exons; Female; Genes, Tumor Suppressor; Genotype; Guanine; Homozygote; Humans; Logistic Models; Middle Aged; Nuclear Proteins; Odds Ratio; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Thymine; Tumor Protein p73; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2003
Inactivated tumor suppressor Rb by nitric oxide promotes mitosis in human breast cancer cells.
    Journal of cellular biochemistry, 2004, May-01, Volume: 92, Issue:1

    Topics: Arginine; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Female; Humans; Mitosis; Nitric Oxide; omega-N-Methylarginine; Phosphorylation; Retinoblastoma Protein; Serine; Tumor Suppressor Protein p53

2004
Arginine482 to threonine mutation in the breast cancer resistance protein ABCG2 inhibits rhodamine 123 transport while increasing binding.
    The Biochemical journal, 2004, Sep-01, Volume: 382, Issue:Pt 2

    Topics: Amino Acid Substitution; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport, Active; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Multiple; Humans; Mutation, Missense; Neoplasm Proteins; Protein Binding; Rhodamine 123; Threonine

2004
Tumour cell growth in culture: dependence on arginine.
    Clinical science (London, England : 1979), 2004, Volume: 107, Issue:4

    Topics: Arginase; Arginine; Breast Neoplasms; Cell Culture Techniques; Cell Division; Cell Line, Tumor; Female; Humans; Leucine; Nitric Oxide; Protein Biosynthesis; Proteins; Signal Transduction

2004
Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.
    Cancer letters, 2004, Jul-16, Volume: 210, Issue:2

    Topics: Adult; Aged; Arginine; Breast Neoplasms; Case-Control Studies; Codon; DNA Mutational Analysis; Female; Genes, p53; Genetic Predisposition to Disease; Humans; Japan; Menopause; Middle Aged; Polymorphism, Genetic; Proline; Receptors, Estrogen; Risk Factors

2004
Arginine-482 is not essential for transport of antibiotics, primary bile acids and unconjugated sterols by the human breast cancer resistance protein (ABCG2).
    The Biochemical journal, 2005, Jan-15, Volume: 385, Issue:Pt 2

    Topics: Amino Acid Substitution; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile Acids and Salts; Biological Transport; Breast Neoplasms; Estradiol; Gene Expression Regulation; Glycine; Humans; Lactococcus lactis; Methotrexate; Mutation, Missense; Neoplasm Proteins; Rhodamine 123; Sterols

2005
Modulation of cathepsin D routing by IGF-II involves IGF-II binding to IGF-II/M6P receptor in MCF-7 breast cancer cells.
    Growth factors (Chur, Switzerland), 2004, Volume: 22, Issue:3

    Topics: Animals; Arginine; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cathepsin D; Cell Line; Cell Line, Tumor; Culture Media, Conditioned; DNA, Complementary; Dose-Response Relationship, Drug; Genetic Vectors; Humans; Immunoblotting; Immunoprecipitation; Insulin-Like Growth Factor II; Lysosomes; Mice; Microsomes, Liver; Radioimmunoassay; RNA, Messenger; Time Factors; Transfection

2004
Ubiquitination and degradation of the Arg tyrosine kinase is regulated by oxidative stress.
    Oncogene, 2005, Apr-07, Volume: 24, Issue:15

    Topics: Arginine; Breast Neoplasms; Female; Humans; Hydrogen Peroxide; Oxidants; Oxidative Stress; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-abl; Tumor Cells, Cultured; Ubiquitins

2005
Plasma arginine concentrations are reduced in cancer patients: evidence for arginine deficiency?
    The American journal of clinical nutrition, 2005, Volume: 81, Issue:5

    Topics: Adult; Aged; Arginine; Breast Neoplasms; Case-Control Studies; Colonic Neoplasms; Female; Humans; Male; Middle Aged; Neoplasms; Pancreatic Neoplasms; Weight Loss

2005
Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.
    The Journal of biological chemistry, 2005, Oct-14, Volume: 280, Issue:41

    Topics: Alanine; Arginine; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Separation; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Genes, Tumor Suppressor; Glutathione; Glutathione Transferase; HeLa Cells; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Hydrogen Peroxide; Immunoprecipitation; Male; Microscopy, Fluorescence; Neoplasm Metastasis; Oxidative Stress; Plasmids; Point Mutation; Prostatic Neoplasms; Protein Binding; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Transfection; Two-Hybrid System Techniques

2005
FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.
    Cellular signalling, 2006, Volume: 18, Issue:6

    Topics: Alleles; Amino Acid Substitution; Arginine; Breast Neoplasms; Cell Line; Cell Movement; Cells, Cultured; Disease Progression; Down-Regulation; Female; Gene Expression Regulation; Glycine; Humans; Polymorphism, Single Nucleotide; Protein Isoforms; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Lysophosphatidic Acid; Signal Transduction

2006
Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: a case control analysis.
    Oncology reports, 2006, Volume: 15, Issue:1

    Topics: Adult; Alanine; Amino Acid Substitution; Arginine; Asian People; Breast Neoplasms; Case-Control Studies; China; DNA-Binding Proteins; Female; Genetic Predisposition to Disease; Glutamic Acid; Humans; Middle Aged; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Polymorphism, Genetic; Risk; Valine; X-ray Repair Cross Complementing Protein 1

2006
Association between TP53 and p21 genetic polymorphisms and acute side effects of radiotherapy in breast cancer patients.
    Breast cancer research and treatment, 2006, Volume: 97, Issue:3

    Topics: Arginine; Body Mass Index; Breast Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Linkage Disequilibrium; Middle Aged; Polymorphism, Genetic; Proline; Proportional Hazards Models; Radiodermatitis; Radiotherapy; Retrospective Studies; Serine; Tumor Suppressor Protein p53

2006
Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells.
    Journal of the National Cancer Institute, 2005, Dec-07, Volume: 97, Issue:23

    Topics: Adenoviridae; Alanine; Animals; Arginine; Blotting, Western; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; DNA-Binding Proteins; DNA, Complementary; Female; Gene Expression Regulation, Neoplastic; Gene Transfer Techniques; Glycine; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Mutagenesis, Insertional; Neoplasm Invasiveness; Polymerase Chain Reaction; Proline; Proto-Oncogene Proteins; Repressor Proteins; Signal Transduction; Smad6 Protein; Smad7 Protein; Transforming Growth Factor beta; Up-Regulation

2005
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
    Cancer letters, 2006, Jan-08, Volume: 231, Issue:1

    Topics: Adenocarcinoma; Arginine; Breast Neoplasms; Humans; Hydrolases; Lung Neoplasms; Neoplasms; Nitric Oxide; Nitric Oxide Synthase; Polyamines; Protein Biosynthesis; Tumor Cells, Cultured

2006
FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Aug-10, Volume: 24, Issue:23

    Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Arginine; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Disease Progression; Drug Resistance, Neoplasm; Female; Genetic Markers; Genotype; Glycine; Humans; Immunohistochemistry; Middle Aged; Multivariate Analysis; Mutation, Missense; Phenotype; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Receptor, Fibroblast Growth Factor, Type 4

2006
Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice.
    Cancer research, 2006, Aug-01, Volume: 66, Issue:15

    Topics: Animals; Arginine; Breast Neoplasms; Cell Adhesion; Cell Growth Processes; Green Fluorescent Proteins; HT29 Cells; Humans; Leucine; Mice; Mice, Nude; Neoplasm Invasiveness; Salmonella typhimurium; Transfection; Xenograft Model Antitumor Assays

2006
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53.
    Nature genetics, 2006, Volume: 38, Issue:10

    Topics: Amino Acid Sequence; Apoptosis; Arginine; Binding Sites; Breast Neoplasms; Carcinoma; Cells, Cultured; Codon; Conserved Sequence; Female; Gene Expression Regulation; Homozygote; Humans; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Polymorphism, Genetic; Proline; Repressor Proteins; Tumor Suppressor Protein p53; Tyrosine

2006
Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Cancer detection and prevention, 2006, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alleles; Arginine; Brazil; Breast Neoplasms; Carcinoma, Ductal; Carcinoma, Lobular; Codon; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; Middle Aged; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proline; Risk Factors

2006
hCAF1, a new regulator of PRMT1-dependent arginine methylation.
    Journal of cell science, 2007, Feb-15, Volume: 120, Issue:Pt 4

    Topics: Adaptor Proteins, Signal Transducing; Arginine; Breast Neoplasms; Cell Line, Tumor; DNA-Binding Proteins; Female; Gene Expression Regulation; HeLa Cells; Histones; Humans; Methylation; Protein-Arginine N-Methyltransferases; Recombinant Fusion Proteins; RNA-Binding Proteins; RNA, Small Interfering; Transcription Factors

2007
The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia.
    British journal of cancer, 2007, Apr-23, Volume: 96, Issue:8

    Topics: Alleles; Apoptosis; Arginine; Breast Neoplasms; Cell Hypoxia; Codon; Female; Genes, p53; Humans; Proline

2007
Anti-tumor activity of arginine deiminase via arginine deprivation in retinoblastoma.
    Oncology reports, 2007, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Antineoplastic Agents; Arginine; Argininosuccinate Synthase; Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Eye Enucleation; Eye Neoplasms; Female; Humans; Hydrolases; Recombinant Proteins; Retinoblastoma

2007
Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants?
    Breast cancer research : BCR, 2007, Volume: 9, Issue:6

    Topics: Alanine; Arginine; Biomarkers, Tumor; Breast Neoplasms; Centrosome; DNA, Complementary; Factor Analysis, Statistical; Female; Genes, BRCA1; Genetic Predisposition to Disease; Glutamic Acid; Glutamine; Glycine; Humans; Immunohistochemistry; Keratins; Mutation, Missense; Nucleic Acid Amplification Techniques; Plasmids; Polymorphism, Single Nucleotide; Predictive Value of Tests; Receptors, Estrogen; Risk Assessment; Risk Factors; Sequence Analysis, DNA; Valine

2007
The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
    Breast cancer research and treatment, 2008, Volume: 112, Issue:2

    Topics: Animals; Anticoagulants; Arginine; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Female; Humans; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Osteopontin; Pipecolic Acids; Platelet Aggregation Inhibitors; Receptors, Thrombin; Sulfonamides; Thrombin

2008
Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine.
    Science (New York, N.Y.), 1981, Oct-02, Volume: 214, Issue:4516

    Topics: Arginine; Breast Neoplasms; Bucladesine; Cell Division; Cell Survival; Cells, Cultured; Cyclic AMP; Drug Synergism; Female; Growth Inhibitors; Humans

1981
The effect of tamoxifen on plasma growth hormone and prolactin in postmenopausal women with advanced breast cancer.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:7

    Topics: Aged; Arginine; Breast Neoplasms; Female; Growth Hormone; Humans; Menopause; Middle Aged; Prolactin; Tamoxifen

1983
Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells.
    Cancer research, 1995, Nov-15, Volume: 55, Issue:22

    Topics: Arginine; Breast Neoplasms; Cyclic GMP; Female; Humans; Nitric Oxide; Nitric Oxide Synthase; Relaxin; Thymidine; Tumor Cells, Cultured

1995
The human plakoglobin gene localizes on chromosome 17q21 and is subjected to loss of heterozygosity in breast and ovarian cancers.
    Proceedings of the National Academy of Sciences of the United States of America, 1995, Jul-03, Volume: 92, Issue:14

    Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Blotting, Southern; BRCA1 Protein; Breast Neoplasms; Cell Adhesion Molecules; Cell Line; Chromosome Deletion; Chromosome Mapping; Chromosomes, Human, Pair 17; Cosmids; Cricetinae; Cytoskeletal Proteins; Desmoplakins; DNA; DNA Primers; DNA, Neoplasm; Exons; Family; Female; gamma Catenin; Genetic Markers; Histidine; Humans; Hybrid Cells; Mice; Molecular Sequence Data; Neoplasm Proteins; Ovarian Neoplasms; Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Transcription Factors

1995
A novel p53 mutant in human breast cancer revealed by multiple SSCP analysis.
    Cancer letters, 1994, Apr-29, Volume: 79, Issue:1

    Topics: Amino Acid Sequence; Animals; Arginine; Base Sequence; Breast Neoplasms; Chickens; Codon; Conserved Sequence; DNA Primers; Exons; Female; Gene Amplification; Genes, p53; Haplorhini; Histidine; Humans; Mice; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Rats; Sequence Homology, Amino Acid; Trout; Tumor Suppressor Protein p53; Xenopus

1994
L-arginine stimulates host defenses in patients with breast cancer.
    Surgery, 1994, Volume: 115, Issue:2

    Topics: Aged; Arginine; Breast Neoplasms; Cytokines; Cytotoxicity, Immunologic; Female; Humans; Immunization; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Lymphocyte Subsets; Middle Aged; Mitogens; Phenotype

1994
Functional analysis of a p21WAF1,CIP1,SDI1 mutant (Arg94 --> Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases.
    The Journal of biological chemistry, 1996, Jun-28, Volume: 271, Issue:26

    Topics: Arginine; Base Sequence; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinases; Cyclins; DNA Primers; Female; Humans; Molecular Sequence Data; Oncogene Proteins; Point Mutation; Protein Binding; Structure-Activity Relationship; Tryptophan

1996
ZR-75-1 human breast cancer cells: expression of inducible nitric oxide synthase and effect of tamoxifen and phorbol ester on nitric oxide production.
    Cancer letters, 1998, Jan-16, Volume: 123, Issue:1

    Topics: Arginine; Breast Neoplasms; Female; Humans; Immunoenzyme Techniques; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Tamoxifen; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured

1998
(Arg15, Arg21) VIP: evaluation of biological activity and localization to breast cancer tumors.
    Peptides, 1998, Volume: 19, Issue:3

    Topics: Amino Acid Sequence; Animals; Arginine; Breast Neoplasms; Cyclic AMP; Gene Expression; Genes, fos; Humans; Mice; Mice, Nude; Molecular Sequence Data; Neoplasm Transplantation; Receptors, Vasoactive Intestinal Peptide; RNA, Messenger; Structure-Activity Relationship; Tissue Distribution; Transplantation, Heterologous; Tumor Cells, Cultured; Vasoactive Intestinal Peptide

1998
p53 polymorphism and risk of cervical cancer.
    Nature, 1998, Dec-10, Volume: 396, Issue:6711

    Topics: Alleles; Arginine; Breast Neoplasms; DNA-Binding Proteins; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Humans; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus Infections; Polymorphism, Genetic; Repressor Proteins; Risk Factors; Tumor Suppressor Protein p53; Tumor Virus Infections; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms

1998
G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation.
    Proceedings of the National Academy of Sciences of the United States of America, 1999, Feb-16, Volume: 96, Issue:4

    Topics: Amino Acid Substitution; Apoptosis; Arginine; Breast Neoplasms; Cell Cycle; Cell Division; Cell Nucleus; Cell Transformation, Neoplastic; DNA-Binding Proteins; Female; G1 Phase; Genes, Reporter; Genes, Tumor Suppressor; Humans; In Situ Nick-End Labeling; Kinetics; Mutagenesis, Site-Directed; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Smad4 Protein; Threonine; Trans-Activators; Transfection; Tumor Cells, Cultured

1999
The additionally glycosylated variant of human sex hormone-binding globulin (SHBG) is linked to estrogen-dependence of breast cancer.
    Breast cancer research and treatment, 1999, Volume: 54, Issue:2

    Topics: Amino Acid Substitution; Arginine; Asparagine; Base Sequence; Breast; Breast Neoplasms; Cell Division; Estradiol; Exons; Female; Fibrocystic Breast Disease; Genetic Variation; Glycosylation; Humans; Point Mutation; Polymorphism, Restriction Fragment Length; Reference Values; Sex Hormone-Binding Globulin

1999
Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
    Cancer research, 2000, Jun-15, Volume: 60, Issue:12

    Topics: Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Cycle; Cell Division; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Synthase; Ornithine; Reverse Transcriptase Polymerase Chain Reaction; Spermine; Tumor Cells, Cultured

2000
p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
    Molecular cell biology research communications : MCBRC, 2000, Volume: 3, Issue:6

    Topics: Adult; Alleles; Amino Acid Substitution; Arginine; Breast Neoplasms; Codon; Female; Gene Frequency; Genetic Predisposition to Disease; Homozygote; Humans; Middle Aged; Neoplasm Staging; Polymorphism, Genetic; Proline; Receptors, Estrogen; Receptors, Progesterone; Tumor Suppressor Protein p53

2000
In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.
    International journal of oncology, 2001, Volume: 18, Issue:1

    Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Arginine; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Female; Glycine; Humans; Point Mutation; Prolactin; Transforming Growth Factor alpha; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Cells, Cultured

2001
Phenol sulfotransferases: hormonal regulation, polymorphism, and age of onset of breast cancer.
    Cancer research, 2000, Dec-15, Volume: 60, Issue:24

    Topics: Adult; Age of Onset; Alleles; Arginine; Arylsulfotransferase; Blotting, Northern; Breast Neoplasms; Case-Control Studies; Estrogens; Exons; Female; Genotype; Histidine; Humans; Immunoblotting; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Tamoxifen; Tumor Cells, Cultured

2000
Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.
    Cancer research, 2001, Feb-01, Volume: 61, Issue:3

    Topics: Adenocarcinoma; Animals; Arginase; Arginine; Biogenic Polyamines; Breast Neoplasms; Cell Division; Coculture Techniques; Cytotoxicity, Immunologic; Humans; Macrophage Activation; Macrophages; Mice; Nitric Oxide; Ornithine; Rats; Transfection; Valine

2001
Disruption of protein phosphatase 2A subunit interaction in human cancers with mutations in the A alpha subunit gene.
    Oncogene, 2001, Jan-04, Volume: 20, Issue:1

    Topics: Amino Acid Sequence; Arginine; Aspartic Acid; Breast Neoplasms; Female; Glutamic Acid; Glycine; Humans; Lung Neoplasms; Melanoma; Molecular Sequence Data; Neoplasms; Peptide Fragments; Phosphoprotein Phosphatases; Point Mutation; Protein Binding; Protein Phosphatase 2; Protein Structure, Secondary; Tryptophan

2001
Inhibition of HIF-1- and wild-type p53-stimulated transcription by codon Arg175 p53 mutants with selective loss of functions.
    Carcinogenesis, 2001, Volume: 22, Issue:6

    Topics: Arginine; bcl-2-Associated X Protein; Binding Sites; Breast Neoplasms; Codon; Consensus Sequence; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Female; Humans; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mutation; Nuclear Proteins; Promoter Regions, Genetic; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Substrate Specificity; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2001
Activation of caspase-3 activity and apoptosis in MDA-MB-468 cells by N(omega)-hydroxy-L-arginine, an inhibitor of arginase, is not solely dependent on reduction in intracellular polyamines.
    Carcinogenesis, 2001, Volume: 22, Issue:11

    Topics: Adenosylmethionine Decarboxylase; Apoptosis; Arginase; Arginine; Blotting, Western; Breast Neoplasms; Caspase 3; Caspases; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Activation; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Ornithine; Ornithine Decarboxylase; Polyamines; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured

2001
Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele.
    Cancer research, 2002, Feb-01, Volume: 62, Issue:3

    Topics: Alleles; Amino Acid Sequence; Arginine; Breast Neoplasms; Cell Movement; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Genotype; Humans; Molecular Sequence Data; Mutation, Missense; Polymorphism, Single Nucleotide; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Tumor Cells, Cultured

2002
Hormonal changes following hypophysectomy in humans.
    Obstetrics and gynecology, 1977, Volume: 50, Issue:3

    Topics: Androstenedione; Arginine; Breast Neoplasms; Cold Temperature; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypophysectomy; Luteinizing Hormone; Pituitary Hormones; Prolactin; Testosterone; Thyrotropin; Thyrotropin-Releasing Hormone

1977
Mapping the cellular distribution of labelled molecules by SIMS microscopy.
    Biology of the cell, 1992, Volume: 74, Issue:1

    Topics: Adenine; Adult; Arginine; Breast Neoplasms; Carbon Radioisotopes; Cells, Cultured; Deuterium; Female; Fibroblasts; Humans; Mass Spectrometry; Microscopy; Nitrogen Isotopes; Thymidine; Tumor Cells, Cultured

1992
Amino acid profiles correlate diagnostically with organ site in three kinds of malignant tumors.
    Cancer, 1992, May-01, Volume: 69, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Alanine; Amino Acids; Arginine; Breast Neoplasms; Carcinoma, Squamous Cell; Discriminant Analysis; Female; Gastrointestinal Neoplasms; Head and Neck Neoplasms; Humans; Male; Middle Aged; Sex Factors; Threonine

1992
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1986, Volume: 7, Issue:5

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Arginine; Argininosuccinic Acid; Blood Platelets; Breast Neoplasms; Creatinine; Dipyridamole; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Plasmapheresis; Sulfinpyrazone; Tablets, Enteric-Coated; Time Factors

1986
Letter: Growth hormone after transsphenoidal hypophysectomy.
    JAMA, 1974, Mar-18, Volume: 227, Issue:11

    Topics: Arginine; Breast Neoplasms; Female; Growth Hormone; Humans; Hypophysectomy; Methods; Neoplasm Metastasis; Radioimmunoassay; Sphenoid Bone

1974
Reversal of multidrug resistance by mitochondrial targeted self-assembled nanocarrier based on stearylamine.
    Molecular pharmaceutics, 2013, Jun-03, Volume: 10, Issue:6

    Topics: Amines; Animals; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; MCF-7 Cells; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Rats; Rats, Sprague-Dawley; Teniposide

2013
Preparation and evaluation of teniposide-loaded polymeric micelles for breast cancer therapy.
    International journal of pharmaceutics, 2016, Nov-20, Volume: 513, Issue:1-2

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Breast Neoplasms; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Half-Life; Humans; Hydrophobic and Hydrophilic Interactions; Maximum Tolerated Dose; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Micelles; Particle Size; Polyesters; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Solubility; Teniposide; Xenograft Model Antitumor Assays

2016
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Apr-01, Volume: 11, Issue:7

    Topics: Antibiotics, Antineoplastic; bcl-2-Associated X Protein; Blotting, Western; Breast Neoplasms; Camptothecin; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Clone Cells; Cyclin-Dependent Kinase Inhibitor p21; Doxorubicin; Drug Resistance, Neoplasm; Gamma Rays; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Immediate-Early Proteins; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Telomerase; Teniposide; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2005
Clinical trials in cancer medicine.
    Australian family physician, 1980, Volume: 9, Issue:1

    Topics: Adult; Antineoplastic Agents; Bleomycin; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Etoposide; Female; Humans; Male; Methotrexate; Platinum; Tamoxifen; Teniposide; Testicular Neoplasms

1980
Combination chemotherapy for metastatic brain tumors.
    Tumori, 1981, Dec-31, Volume: 67, Issue:6

    Topics: Adenocarcinoma; Brain Neoplasms; Breast Neoplasms; Carcinoma, Small Cell; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Nitrosourea Compounds; Podophyllotoxin; Prognosis; Teniposide; Tomography, X-Ray Computed

1981
Phase II study of VM 26 in extensively pretreated breast cancer.
    American journal of clinical oncology, 1984, Volume: 7, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Teniposide

1984
Primary lymphoblastic lymphoma of the breast.
    Clinical oncology, 1982, Volume: 8, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Lymphoma, Non-Hodgkin; Prednisone; Teniposide; Vincristine

1982
Phase II study of VM-26 in adult malignancies.
    Cancer treatment reports, 1980, Volume: 64, Issue:1

    Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia

1980
Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26.
    Biochimica et biophysica acta, 1995, Jun-09, Volume: 1262, Issue:2-3

    Topics: Breast Neoplasms; Cell Line; DNA; Down-Regulation; Gene Expression; Humans; Proto-Oncogene Proteins c-myc; Teniposide; Topoisomerase II Inhibitors; Transcription, Genetic

1995
Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance.
    Cancer research, 1994, Jan-01, Volume: 54, Issue:1

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Carrier Proteins; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance; Etoposide; Female; Humans; Membrane Glycoproteins; RNA, Messenger; Teniposide; Tumor Cells, Cultured

1994
Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.
    Cancer research, 1993, Aug-01, Volume: 53, Issue:15

    Topics: Blotting, Southern; Breast Neoplasms; Cell Division; DNA Damage; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, myc; Humans; RNA, Neoplasm; Teniposide; Tumor Cells, Cultured

1993
The vascular compartment hampers accurate determination of teniposide penetration into brain tumor tissue.
    Cancer chemotherapy and pharmacology, 1997, Volume: 40, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Breast Neoplasms; Capillary Permeability; Cerebrovascular Circulation; Female; Glioblastoma; Humans; Male; Melanoma; Middle Aged; Oligodendroglioma; Skin Neoplasms; Teniposide

1997
Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cells.
    Molecular pharmacology, 1997, Volume: 52, Issue:3

    Topics: Antineoplastic Agents, Phytogenic; Binding Sites; Breast Neoplasms; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; E2F Transcription Factors; Humans; Luciferases; Phosphorylation; Plasmids; Retinoblastoma Protein; Retinoblastoma-Binding Protein 1; Signal Transduction; Teniposide; Transcription Factor DP1; Transcription Factors; Transfection; Tumor Cells, Cultured

1997
Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:1

    Topics: Amsacrine; Bleomycin; Breast Neoplasms; Cell Division; Cell Survival; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; DNA Topoisomerases, Type II; Etoposide; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genes, ras; Humans; Recombinant Proteins; Teniposide; Topoisomerase II Inhibitors; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured

1995
Anticancer drugs induce increased mitochondrial cytochrome c expression that precedes cell death.
    Cancer research, 2001, Feb-01, Volume: 61, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Caspase 3; Caspase 9; Caspases; Cell Adhesion; Cytochrome c Group; DNA Fragmentation; Electron Transport; Electron Transport Complex IV; Enzyme Activation; Humans; Intracellular Membranes; Membrane Potentials; Microscopy, Fluorescence; Mitochondria; Poly(ADP-ribose) Polymerases; Teniposide; Tumor Cells, Cultured; Up-Regulation

2001
Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.
    Biochemical pharmacology, 2001, Sep-01, Volume: 62, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Death; DNA Damage; G1 Phase; Gene Expression; Gene Silencing; Humans; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Proto-Oncogene Proteins c-myc; Teniposide; Transcription, Genetic; Tumor Cells, Cultured

2001
Primary breast lymphoma: a report of 20 cases.
    British journal of haematology, 2001, Volume: 115, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Middle Aged; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Rate; Teniposide; Treatment Outcome; Vincristine

2001
[Effectiveness of VM 26, mitomycine C and methotrexate in advanced breast cancer refractory to a four drug combination (author's transl)].
    Bulletin du cancer, 1979, Volume: 66, Issue:5

    Topics: Adult; Aged; Breast Neoplasms; Drug Resistance; Drug Therapy, Combination; Female; Humans; Methotrexate; Middle Aged; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide

1979
Phase II study of teniposide in advanced breast cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:6

    Topics: Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Leukopenia; Middle Aged; Podophyllotoxin; Teniposide; Thrombocytopenia

1990
Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial.
    Investigational new drugs, 1988, Volume: 6, Issue:1

    Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Resistance; Female; Humans; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Teniposide

1988